ATE15606T1 - Durch osmose wirksame vorrichtung mit hydrogel als osmotisches mittel. - Google Patents

Durch osmose wirksame vorrichtung mit hydrogel als osmotisches mittel.

Info

Publication number: ATE15606T1
Authority: AT; Austria
Prior art keywords: hydrogel; osmosic; osmotic agent; agent; osmotic
Prior art date: 1980-11-25

Application number

AT81303354T

Other languages

English (en)

Inventor

Richard Cortese

Felix Theeuwes

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-11-25

Filing date

1981-07-22

Publication date

1985-10-15

1981-07-22 Application filed by Alza Corp filed Critical Alza Corp

1985-10-15 Application granted granted Critical

1985-10-15 Publication of ATE15606T1 publication Critical patent/ATE15606T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S604/00—Surgery
- Y10S604/904—Tampons

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
External Artificial Organs (AREA)
Physical Or Chemical Processes And Apparatus (AREA)
Prostheses (AREA)
Colloid Chemistry (AREA)
Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Separation Using Semi-Permeable Membranes (AREA)

AT81303354T 1980-11-25 1981-07-22 Durch osmose wirksame vorrichtung mit hydrogel als osmotisches mittel. ATE15606T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/210,176 US4327725A (en)	1980-11-25	1980-11-25	Osmotic device with hydrogel driving member
EP81303354A EP0052917B1 (de)	1980-11-25	1981-07-22	Durch Osmose wirksame Vorrichtung mit Hydrogel als osmotisches Mittel

Publications (1)

Publication Number	Publication Date
ATE15606T1 true ATE15606T1 (de)	1985-10-15

Family

ID=22781870

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT81303354T ATE15606T1 (de)	1980-11-25	1981-07-22	Durch osmose wirksame vorrichtung mit hydrogel als osmotisches mittel.

Country Status (6)

Country	Link
US (1)	US4327725A (de)
EP (1)	EP0052917B1 (de)
JP (1)	JPS6043045B2 (de)
AT (1)	ATE15606T1 (de)
DE (1)	DE3172338D1 (de)
MX (1)	MX174160B (de)

Families Citing this family (906)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4479795A (en) *	1979-06-29	1984-10-30	The Procter & Gamble Company	Antimicrobial polymer compositions
US4764380A (en) *	1982-03-22	1988-08-16	Alza Corporation	Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
US5366738A (en) *	1982-07-29	1994-11-22	Merck & Co., Inc.	Controlled release drug dispersion delivery device
US4466705A (en) *	1982-09-30	1984-08-21	Michelson Paul E	Fluid lens
US4709996A (en) *	1982-09-30	1987-12-01	Michelson Paul E	Fluid lens
US4613330A (en) *	1982-11-26	1986-09-23	Michelson Paul E	Delivery system for desired agents
GB8305797D0 (en) *	1983-03-02	1983-04-07	Graham N B	Hydrogel-containing envelopes
US5082668A (en) *	1983-05-11	1992-01-21	Alza Corporation	Controlled-release system with constant pushing source
US4783337A (en) *	1983-05-11	1988-11-08	Alza Corporation	Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) *	1983-05-11	1988-08-23	Alza Corporation	Osmotic device for administering certain drugs
AT394944B (de) *	1983-05-11	1992-07-27	Alza Corp	Verfahren zur herstellung einer vorrichtung zur abgabe eines wirkstoffes, insbesondere eines heilmittels, an eine waesserige verwendungsumgebung
NZ206600A (en) *	1983-05-11	1987-01-23	Alza Corp	Osmotic drug delivery device
USRE33994E (en) *	1983-08-16	1992-07-14	Burroughs Wellcome Co.	Pharmaceutical delivery system
US4781714A (en) *	1983-11-02	1988-11-01	Alza Corporation	Dispenser for delivering thermo-responsive composition
US4627850A (en) *	1983-11-02	1986-12-09	Alza Corporation	Osmotic capsule
AU591171B2 (en) *	1983-11-02	1989-11-30	Alza Corporation	Dispenser for delivering thermo-responsive composition
US4772474A (en) *	1985-08-09	1988-09-20	Alza Corporation	Dispenser with internal arrangement of lamina means for dispensing beneficial agent
US5000957A (en) *	1984-03-19	1991-03-19	Alza Corporation	Dispenser comprising hydrophilic osmopolymer
US4717566A (en) *	1984-03-19	1988-01-05	Alza Corporation	Dosage system and method of using same
US4927633A (en) *	1984-03-19	1990-05-22	Alza Corporation	Dispenser for delivering drug to livestock
US4624945A (en) *	1984-03-19	1986-11-25	Alza Corporation	Dispensing system with means for increasing delivery of beneficial agent from the system
US4844984A (en) *	1984-03-19	1989-07-04	Alza Corporation	Dispensing system with means for increasing delivery of beneficial agent from the system
US4595583A (en) *	1984-03-19	1986-06-17	Alza Corporation	Delivery system controlled administration of beneficial agent to ruminants
US4729793A (en) *	1985-08-09	1988-03-08	Alza Corporation	Composition for manufacturing wall of dispensing device
US4692326A (en) *	1984-03-21	1987-09-08	Alza Corporation	Dispenser comprising inner positioned soft or hard capsule
US4814180A (en) *	1984-03-21	1989-03-21	Alza Corporation	Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
US4663149A (en) *	1984-03-21	1987-05-05	Alza Corporation	Dispenser comprising inner and outer walls functioning as cooperative unit
US4663148A (en) *	1984-03-21	1987-05-05	Alza Corporation	Dispenser comprising telescopically engaging members
GB2155889B (en) *	1984-03-21	1988-03-02	Alza Corp	Dispenser-capsule
US4716031A (en) *	1984-03-21	1987-12-29	Alza Corporation	Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4678467A (en) *	1984-03-21	1987-07-07	Alza Corporation	Dispenser comprising capsule with volume displacing member
US4627971A (en) *	1985-04-22	1986-12-09	Alza Corporation	Osmotic device with self-sealing passageway
US4609374A (en) *	1985-04-22	1986-09-02	Alza Corporation	Osmotic device comprising means for governing initial time of agent release therefrom
US4624847A (en) *	1985-04-22	1986-11-25	Alza Corporation	Drug delivery device for programmed delivery of beneficial drug
US4717718A (en) *	1985-08-09	1988-01-05	Alza Corporation	Device for the controlled delivery of a beneficial agent
US4717568A (en) *	1985-08-09	1988-01-05	Alza Corporation	Laminar arrangement for increasing delivery of beneficial agent from dispenser
US4966767A (en) *	1985-08-16	1990-10-30	Alza Corporation	Ruminant dispensing device comprising agent displacement member
US4865598A (en) *	1985-08-16	1989-09-12	Alza Corporation	Dispensing system for administering beneficial agent
US4704118A (en) *	1985-08-16	1987-11-03	Alza Corporation	Ruminant dispensing device with thermo-activated memory
US4883667A (en) *	1985-08-16	1989-11-28	Alza Corporation	Process for forming dispensing device
US4955881A (en) *	1985-08-16	1990-09-11	Alza Corporation	Ruminant dispensing device
US4963141A (en) *	1985-08-16	1990-10-16	Alza Corporation	Dispensing system for administering beneficial agent formulation to ruminants
US4643731A (en) *	1985-08-16	1987-02-17	Alza Corporation	Means for providing instant agent from agent dispensing system
US5098425A (en) *	1985-08-16	1992-03-24	Alza Corporation	Method of administering a ruminant dispensing device comprising density member dispersed in hydrogel member
US4871544A (en) *	1985-08-16	1989-10-03	Alza Corporation	Ruminant dispensing device
US4866040A (en) *	1986-01-06	1989-09-12	Alfred Stracher	Aminocarnitine directed pharmaceutical agents
US5008288A (en) *	1986-01-06	1991-04-16	Alfred Stracher	Carnitine directed pharmaceutical agents
US4971790A (en) *	1986-02-07	1990-11-20	Alza Corporation	Dosage form for lessening irritation of mocusa
US4747847A (en) *	1986-02-07	1988-05-31	Alza Corporation	System for delivering potassium chloride with enhanced bioacceptability
US4867969A (en) *	1986-02-07	1989-09-19	Alza Corporation	Hydrogel formulation for administering non-steroidal drugs
US4723957A (en) *	1986-02-07	1988-02-09	Alza Corp.	System for delivering drug with enhanced bioacceptability
US4865845A (en) *	1986-03-21	1989-09-12	Alza Corporation	Release rate adjustment of osmotic or diffusional delivery devices
US4960416A (en) *	1986-04-30	1990-10-02	Alza Corporation	Dosage form with improved delivery capability
GB2189702B (en) *	1986-04-30	1989-10-18	Alza Corp	Dosage form with improved delivery capability
US4863456A (en) *	1986-04-30	1989-09-05	Alza Corporation	Dosage form with improved delivery capability
US4723958A (en) *	1986-05-23	1988-02-09	Merck & Co., Inc.	Pulsatile drug delivery system
US4755180A (en) *	1986-06-16	1988-07-05	Alza Corporation	Dosage form comprising solubility regulating member
US4983400A (en) *	1986-06-16	1991-01-08	Merck & Co., Inc.	Controlled release combination of carbidopa/levodopa
CH668187A5 (de) *	1986-08-07	1988-12-15	Ciba Geigy Ag	Therapeutisches system mit systemischer wirkung.
USRE34990E (en) *	1986-08-07	1995-07-04	Ciba-Geigy Corporation	Oral therapeutic system having systemic action
EP0277092B1 (de) *	1987-01-14	1992-01-29	Ciba-Geigy Ag	Therapeutisches System für schwerlösliche Wirkstoffe
JPS63180224A (ja) *	1987-01-21	1988-07-25	Matsushita Electric Ind Co Ltd	無線機のアンテナ回路
US4892778A (en) *	1987-05-27	1990-01-09	Alza Corporation	Juxtaposed laminated arrangement
US4940465A (en) *	1987-05-27	1990-07-10	Felix Theeuwes	Dispenser comprising displaceable matrix with solid state properties
US5938654A (en) *	1987-06-25	1999-08-17	Alza Corporation	Osmotic device for delayed delivery of agent
US5391381A (en) *	1987-06-25	1995-02-21	Alza Corporation	Dispenser capable of delivering plurality of drug units
US5340590A (en) *	1987-06-25	1994-08-23	Alza Corporation	Delivery system with bilayer osmotic engine
US5236689A (en) *	1987-06-25	1993-08-17	Alza Corporation	Multi-unit delivery system
US4876093A (en) *	1987-07-02	1989-10-24	Alza Corporation	Dispenser with dispersing member for delivering beneficial agent
US4915949A (en) *	1987-07-13	1990-04-10	Alza Corporation	Dispenser with movable matrix comprising a plurality of tiny pills
US4824675A (en) *	1987-07-13	1989-04-25	Alza Corporation	Dispenser with movable matrix comprising a plurality of tiny pills
US4891223A (en) *	1987-09-03	1990-01-02	Air Products And Chemicals, Inc.	Controlled release delivery coating formulation for bioactive substances
US4816263A (en) *	1987-10-02	1989-03-28	Alza Corporation	Dosage form for treating cardiovascular diseases comprising isradipine
US4946687A (en) *	1987-10-02	1990-08-07	Alza Corporation	Dosage form for treating cardiovascular diseases
US4950486A (en) *	1987-10-02	1990-08-21	Alza Corporation	Dosage form for treating cardiovascular diseases
US4996060A (en) *	1988-03-25	1991-02-26	Alza Corporation	Device comprising liner for protecting fluid sensitive medicament
US4855141A (en) *	1988-03-25	1989-08-08	Alza Corporation	Device comprising means for protecting and dispensing fluid sensitive medicament
US4959218A (en) *	1988-03-25	1990-09-25	Alza Corporation	Method for delivering somatotropin to an animal
US5019397A (en) *	1988-04-21	1991-05-28	Alza Corporation	Aqueous emulsion for pharmaceutical dosage form
US5024842A (en) *	1988-04-28	1991-06-18	Alza Corporation	Annealed coats
US5006346A (en) *	1988-04-28	1991-04-09	Alza Corporation	Delivery system
US4931285A (en) *	1988-04-28	1990-06-05	Alza Corporation	Aqueous based pharmaceutical coating composition for dosage forms
US5030456A (en) *	1988-11-07	1991-07-09	Alza Corporation	Dosage form for treating cardiovascular diseases
US5376383A (en) *	1988-11-21	1994-12-27	Merck & Co., Inc.	Method for enhancing the lowering of plasma-cholesterol levels
US4997658A (en) *	1988-11-21	1991-03-05	Merck & Co., Inc.	Method for enhancing the lowering of plasma cholesterol levels
US5034229A (en) *	1988-12-13	1991-07-23	Alza Corporation	Dispenser for increasing feed conversion of hog
US5037420A (en) *	1988-12-13	1991-08-06	Alza Corporation	Delivery system comprising two sections for delivering somatotropin
US5059423A (en) *	1988-12-13	1991-10-22	Alza Corporation	Delivery system comprising biocompatible beneficial agent formulation
US5174999A (en) *	1988-12-13	1992-12-29	Alza Corporation	Delivery system comprising fluid ingress and drug egress
US5135523A (en) *	1988-12-13	1992-08-04	Alza Corporation	Delivery system for administering agent to ruminants and swine
US5110596A (en) *	1988-12-13	1992-05-05	Alza Corporation	Delivery system comprising means for delivering agent to livestock
US5728088A (en) *	1988-12-13	1998-03-17	Alza Corporation	Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
US5057318A (en) *	1988-12-13	1991-10-15	Alza Corporation	Delivery system for beneficial agent over a broad range of rates
US5108756A (en) *	1989-01-12	1992-04-28	Pfizer Inc.	Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) *	1989-01-12	1995-07-31	Pfizer	Hydrogel-operated release devices
US5030452A (en) *	1989-01-12	1991-07-09	Pfizer Inc.	Dispensing devices powered by lyotropic liquid crystals
DD295760A5 (de) *	1989-01-31	1991-11-14	Martin-Luther-Universitaet Halle Wittenberg,De	Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
IE69174B1 (en) *	1989-01-31	1996-08-07	Int Pharma Agentur	A system for the controlled release of active agents and a process for its preparation
US6200600B1 (en) *	1989-02-16	2001-03-13	Btg International Limited	Controlled delay release device
US5181505A (en) *	1989-03-08	1993-01-26	Lew Chel W	Method and apparatus for delivery of a medicament in the oral cavity
US5002540A (en) *	1989-05-22	1991-03-26	Warren Kirschbaum	Intravaginal device and method for delivering a medicament
US5776493A (en) *	1989-07-14	1998-07-07	Alza Corporation	Oral osmotic device for delivery of nystatin with hydrogel driving member
US5021053A (en) *	1989-07-14	1991-06-04	Alza Corporation	Oral osmotic device with hydrogel driving member
US5273752A (en) *	1989-07-18	1993-12-28	Alza Corporation	Controlled release dispenser comprising beneficial agent
US5126142A (en) *	1989-07-18	1992-06-30	Alza Corporation	Dispenser comprising ionophore
US5035897A (en) *	1989-09-05	1991-07-30	Alza Corporation	Dosage form for delivering soluble or insoluble drugs
US5120548A (en) *	1989-11-07	1992-06-09	Merck & Co., Inc.	Swelling modulated polymeric drug delivery device
US5098714A (en) *	1989-11-16	1992-03-24	Alza Corporation	Osmotic, oral dosage form for fertility control
US5030216A (en) *	1989-12-15	1991-07-09	Alza Corporation	Osmotically driven syringe
US5660851A (en) *	1989-12-26	1997-08-26	Yissum Research Development Company Of The Hebrew Univ. Of Jerusalem	Ocular inserts
US5223266A (en) *	1990-01-24	1993-06-29	Alza Corporation	Long-term delivery device with early startup
US5474785A (en) *	1990-01-24	1995-12-12	Alza Corporation	Delivery system comprising means for controlling internal pressure
US5128145A (en) *	1990-06-13	1992-07-07	Alza Corporation	Dosage form for Parkinson's disease, spasticity and muscle spasms
US5057321A (en) *	1990-06-13	1991-10-15	Alza Corporation	Dosage form comprising drug and maltodextrin
US5238687A (en) *	1990-07-11	1993-08-24	Alza Corporation	Delivery device with a protective sleeve
US5234693A (en) *	1990-07-11	1993-08-10	Alza Corporation	Delivery device with a protective sleeve
US5234694A (en) *	1990-07-11	1993-08-10	Alza Corporation	Method for increasing feed efficiency in animals
US5180591A (en) *	1990-07-11	1993-01-19	Alza Corporation	Delivery device with a protective sleeve
US5234692A (en) *	1990-07-11	1993-08-10	Alza Corporation	Delivery device with a protective sleeve
NZ238867A (en) *	1990-07-12	1993-08-26	Alza Corp	Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5147654A (en) *	1990-07-23	1992-09-15	Alza Corporation	Oral osmotic device for delivering nicotine
ES2053339T3 (es) *	1990-09-28	1994-07-16	Pfizer	Dispositivo dispensador conteniendo un medio hidrofobo.
US5443459A (en) *	1991-01-30	1995-08-22	Alza Corporation	Osmotic device for delayed delivery of agent
US5378475A (en) *	1991-02-21	1995-01-03	University Of Kentucky Research Foundation	Sustained release drug delivery devices
US5593852A (en)	1993-12-02	1997-01-14	Heller; Adam	Subcutaneous glucose electrode
US5861166A (en) *	1991-03-12	1999-01-19	Alza Corporation	Delivery device providing beneficial agent stability
US5208037A (en) *	1991-04-22	1993-05-04	Alza Corporation	Dosage forms comprising polymers comprising different molecular weights
US5198229A (en) *	1991-06-05	1993-03-30	Alza Corporation	Self-retaining gastrointestinal delivery device
US5137727A (en) *	1991-06-12	1992-08-11	Alza Corporation	Delivery device providing beneficial agent stability
US6764697B1 (en)	1991-06-27	2004-07-20	Alza Corporation	System for delaying drug delivery up to seven hours
US5190765A (en) *	1991-06-27	1993-03-02	Alza Corporation	Therapy delayed
US5252338A (en) *	1991-06-27	1993-10-12	Alza Corporation	Therapy delayed
US5160744A (en) *	1991-06-27	1992-11-03	Alza Corporation	Verapmil therapy
US5178867A (en) *	1991-08-19	1993-01-12	Alza Corporation	Dosage form for delivering drug in short-time period
US5240713A (en) *	1991-09-27	1993-08-31	Alza Corporation	Dual rate agent delivery device
NZ244682A (en) *	1991-10-10	1993-12-23	Alza Corp	Osmotically driven controlled delivery device characterised in that a
US5254349A (en) *	1991-12-06	1993-10-19	Alza Corporation	Process for lessening irritation caused by drug
US5200195A (en) *	1991-12-06	1993-04-06	Alza Corporation	Process for improving dosage form delivery kinetics
US5266332A (en) *	1991-12-06	1993-11-30	Alza Corporation	Method for administering anti-Parkinson drug
US5200194A (en) *	1991-12-18	1993-04-06	Alza Corporation	Oral osmotic device
US5543154A (en) *	1991-12-27	1996-08-06	Merck & Co., Inc.	Controlled release nifedipine delivery device
US5223265A (en) *	1992-01-10	1993-06-29	Alza Corporation	Osmotic device with delayed activation of drug delivery
US5330762A (en) *	1992-02-27	1994-07-19	Alza Corporation	Tandospiaine antidepressive therapy
US5185158A (en) *	1992-02-27	1993-02-09	Alza Corporation	Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
US5246710A (en) *	1992-02-27	1993-09-21	Alza Corporation	Dosage form for treating cyclothymia
US5246711A (en) *	1992-02-27	1993-09-21	Alza Corporation	Dosage form for treating dysthymia
US5688518A (en) *	1992-02-27	1997-11-18	Alza Corporation	Antidepressive therapy
US5858407A (en) *	1992-02-27	1999-01-12	Alza Corporation	Method for administering tandospirone
US5248310A (en) *	1992-03-27	1993-09-28	Alza Corporation	Oral osmotic device with hydrogel driving member
US5512299A (en) *	1992-03-30	1996-04-30	Alza Corporation	Method of treating oral inflammatory disease
US5869097A (en)	1992-11-02	1999-02-09	Alza Corporation	Method of therapy comprising an osmotic caplet
US5573776A (en) *	1992-12-02	1996-11-12	Alza Corporation	Oral osmotic device with hydrogel driving member
US5358721A (en) *	1992-12-04	1994-10-25	Alza Corporation	Antiviral therapy
US6440457B1 (en) *	1993-05-27	2002-08-27	Alza Corporation	Method of administering antidepressant dosage form
US6287598B1 (en)	1993-05-28	2001-09-11	Alza Corporation	Method for providing sustained antiepileptic therapy
US5498255A (en) *	1993-08-17	1996-03-12	Alza Corporation	Osmotic device for protracted pulsatile delivery of agent
HU213407B (en) *	1993-12-09	1997-06-30	Egyt Gyogyszervegyeszeti Gyar	Process for producing tablet with diffusive-osmotic release
US5474985A (en) *	1993-12-22	1995-12-12	The Regents Of The University Of California	Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
GB9326267D0 (en) *	1993-12-23	1994-02-23	Scherer Corp R P	Expulsion of material
US5532003A (en) *	1994-01-18	1996-07-02	Alza Corporation	Pentoxifylline therapy
US5540665A (en) *	1994-01-31	1996-07-30	Alza Corporation	Gas driven dispensing device and gas generating engine therefor
ZA953078B (en) *	1994-04-28	1996-01-05	Alza Corp	Effective therapy for epilepsies
US20040191314A1 (en) *	1994-04-28	2004-09-30	Frank Jao	Antiepileptic dosage form and process for protecting antiepileptic drug
US5460826A (en) *	1994-06-27	1995-10-24	Alza Corporation	Morphine therapy
US5698224A (en) *	1994-06-27	1997-12-16	Alza Corporation	Tacrine therapy
US5529787A (en) *	1994-07-07	1996-06-25	Alza Corporation	Hydromorphone therapy
US5914131A (en) *	1994-07-07	1999-06-22	Alza Corporation	Hydromorphone therapy
US5633011A (en) *	1994-08-04	1997-05-27	Alza Corporation	Progesterone replacement therapy
IE70735B1 (en) *	1994-08-15	1996-12-11	Elan Med Tech	Orally administrable delivery device
US5837276A (en)	1994-09-02	1998-11-17	Delab	Apparatus for the delivery of elongate solid drug compositions
US5582591A (en) *	1994-09-02	1996-12-10	Delab	Delivery of solid drug compositions
US6491945B1 (en)	1994-09-16	2002-12-10	Alza Corporation	Hydrocodone therapy
US5614578A (en) *	1994-10-28	1997-03-25	Alza Corporation	Injection-molded dosage form
US5582838A (en) *	1994-12-22	1996-12-10	Merck & Co., Inc.	Controlled release drug suspension delivery device
US5534263A (en)	1995-02-24	1996-07-09	Alza Corporation	Active agent dosage form comprising a matrix and at least two insoluble bands
US5651979A (en) *	1995-03-30	1997-07-29	Gel Sciences, Inc.	Apparatus and method for delivering a biologically active compound into a biological environment
US5876741A (en) *	1995-03-30	1999-03-02	Medlogic Global Corporation	Chemo-mechanical expansion delivery system
SI9500173B (sl) *	1995-05-19	2002-02-28	Lek,	Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
US5912268A (en) *	1995-05-22	1999-06-15	Alza Corporation	Dosage form and method for treating incontinence
US6124355A (en) *	1995-05-22	2000-09-26	Guittard; George V.	Oxybutynin therapy
US6262115B1 (en) *	1995-05-22	2001-07-17	Alza Coporation	Method for the management of incontinence
US5674895A (en) *	1995-05-22	1997-10-07	Alza Corporation	Dosage form comprising oxybutynin
US5817335A (en) *	1995-05-26	1998-10-06	Alza Corporation	Osmotic device with high drug loading and delayed activation of drug delivery
US5800422A (en) *	1995-06-02	1998-09-01	Alza Corporation	Osmotic device with delayed activation of drug delivery and complete drug release
US5869079A (en) *	1995-06-02	1999-02-09	Oculex Pharmaceuticals, Inc.	Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20060280774A1 (en) *	1995-06-02	2006-12-14	Allergan, Inc.	Compositions and methods for treating glaucoma
US5690952A (en) *	1995-06-07	1997-11-25	Judy A. Magruder et al.	Implantable system for delivery of fluid-sensitive agents to animals
US5731001A (en) *	1995-06-07	1998-03-24	Magruder; Judy A.	Locking couplings for osmotic delivery devices
US5674888A (en) *	1995-06-07	1997-10-07	University Of California	Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5713852A (en) *	1995-06-07	1998-02-03	Alza Corporation	Oral dosage and method for treating painful conditions of the oral cavity
US5599535A (en) *	1995-06-07	1997-02-04	Regents Of The University Of California	Methods for the cyto-protection of the trabecular meshwork
US5780058A (en)	1995-07-21	1998-07-14	Alza Corporation	Oral delivery of discrete units
US5840332A (en) *	1996-01-18	1998-11-24	Perio Products Ltd.	Gastrointestinal drug delivery system
PT914097E (pt) *	1996-03-12	2002-06-28	Alza Corp	Composicao e forma de dosagem compreendendo antagonista de opioide
US6096339A (en) *	1997-04-04	2000-08-01	Alza Corporation	Dosage form, process of making and using same
ZA97976B (en) *	1996-04-05	1997-08-18	Alza Corp	Uniform drug delivery theraphy.
US5902605A (en) *	1996-04-18	1999-05-11	Alza Corporation	Drug delivery device with minimal residual drug retention
WO1998006380A2 (en) *	1996-08-16	1998-02-19	Alza Corporation	Dosage form for providing ascending dose of drug
US6024721A (en)	1996-10-18	2000-02-15	Alza Corporation	Mixing system for an active agent delivery device
AU729905B2 (en) *	1996-10-18	2001-02-15	Alza Corporation	Multiple flow path device for oral delivery of discrete units
ATE205381T1 (de) *	1996-10-18	2001-09-15	Alza Corp	Austragevorrichtung für aktive wirkstoffe
ES2255103T3 (es) *	1996-10-25	2006-06-16	Shire Laboratories Inc.	Sistema osmotico de administracion de dosis en forma soluble.
US6361796B1 (en)	1996-10-25	2002-03-26	Shire Laboratories, Inc.	Soluble form osmotic dose delivery system
US6919373B1 (en) *	1996-11-12	2005-07-19	Alza Corporation	Methods and devices for providing prolonged drug therapy
DE69735848T2 (de) *	1996-11-25	2006-12-28	Alza Corp., Palo Alto	Dosisform mit ansteigender dosisfreisetzung
EP1782798A3 (de)	1996-11-25	2008-05-21	Alza Corporation	Darreichungsform mit ansteigender Dosisfreisetzung
US5788987A (en)	1997-01-29	1998-08-04	Poli Industria Chimica Spa	Methods for treating early morning pathologies
US5922352A (en) *	1997-01-31	1999-07-13	Andrx Pharmaceuticals, Inc.	Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) *	1997-01-31	1998-11-17	Andrx Pharmaceuticals, Inc.	Once daily pharmaceutical tablet having a unitary core
US20030100532A1 (en) *	1997-02-14	2003-05-29	Gary S. Jacob	Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
US5948787A (en) *	1997-02-28	1999-09-07	Alza Corporation	Compositions containing opiate analgesics
ATE221762T1 (de) *	1997-05-16	2002-08-15	Alza Corp	Durchflussreglerkonfigurationen für ein wirkstoff abgebendes gerät
US6110499A (en) *	1997-07-24	2000-08-29	Alza Corporation	Phenytoin therapy
US5902598A (en) *	1997-08-28	1999-05-11	Control Delivery Systems, Inc.	Sustained release drug delivery devices
US6514530B2 (en)	1997-09-09	2003-02-04	Alza Corporation	Dosage form comprising means for changing drug delivery shape
PT1014951E (pt)	1997-09-09	2005-03-31	Alza Corp	Composicao de revestimento farmaceutica e metodo para a sua utilizacao
US7060734B1 (en)	1997-09-09	2006-06-13	Alza Corporation	Pharmaceutical coating composition and method of use
US20040062799A1 (en) *	1997-09-29	2004-04-01	Ayer Atul D.	Therapeutic composition and delivery system for administering drug
MY122499A (en)	1997-11-10	2006-04-29	Searle & Co	Use of alkylated iminosugars to treat multidrug resistance
AU1534699A (en)	1997-12-05	1999-06-28	Alza Corporation	Osmotic dosage form comprising first and second coats
US6485748B1 (en)	1997-12-12	2002-11-26	Andrx Pharmaceuticals, Inc.	Once daily pharmaceutical tablet having a unitary core
PT1041975E (pt)	1997-12-22	2003-01-31	Alza Corp	Membranas de controlo de taxa para dispositivos de fornecimento controlado de drogas
KR20010040937A (ko)	1998-02-12	2001-05-15	윌리암스 로저 에이	간염 바이러스 감염의 치료를 위한 ｎ-치환된1,5-디데옥시-1,5-이미노-ｄ-글루시톨 화합물의 용도
US6689759B1 (en)	1998-02-12	2004-02-10	G. D. Searle & Co.	Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6134461A (en)	1998-03-04	2000-10-17	E. Heller & Company	Electrochemical analyte
US6245357B1 (en)	1998-03-06	2001-06-12	Alza Corporation	Extended release dosage form
US8524277B2 (en) *	1998-03-06	2013-09-03	Alza Corporation	Extended release dosage form
US6099859A (en)	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
AR018321A1 (es) *	1998-03-26	2001-11-14	Alza Corp	Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
US6175752B1 (en)	1998-04-30	2001-01-16	Therasense, Inc.	Analyte monitoring device and methods of use
US8480580B2 (en)	1998-04-30	2013-07-09	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8688188B2 (en)	1998-04-30	2014-04-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8974386B2 (en)	1998-04-30	2015-03-10	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8465425B2 (en)	1998-04-30	2013-06-18	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8346337B2 (en)	1998-04-30	2013-01-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US6949816B2 (en)	2003-04-21	2005-09-27	Motorola, Inc.	Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US9066695B2 (en)	1998-04-30	2015-06-30	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US6365183B1 (en)	1998-05-07	2002-04-02	Alza Corporation	Method of fabricating a banded prolonged release active agent dosage form
KR100827254B1 (ko)	1998-06-03	2008-05-07	알자 코포레이션	연장된 약물 치료를 제공하기 위한 방법 및 장치
US20010038855A1 (en) *	1998-06-05	2001-11-08	Desjardin Michael A.	Dosage form for administering prescribed dose
US7890176B2 (en) *	1998-07-06	2011-02-15	Boston Scientific Neuromodulation Corporation	Methods and systems for treating chronic pelvic pain
US6524620B2 (en)	1998-07-20	2003-02-25	Andrx Pharmaceuticals, Inc.	Diltiazem controlled release formulation and method of manufacture
US7303768B2 (en)	1998-07-24	2007-12-04	Seo Hong Yoo	Preparation of aqueous clear solution dosage forms with bile acids
CN1205922C (zh)	1998-07-24	2005-06-15	柳署弘	制备含有胆汁酸的澄清水溶液剂型
US20050158408A1 (en) *	1998-07-24	2005-07-21	Yoo Seo H.	Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US7772220B2 (en) *	2004-10-15	2010-08-10	Seo Hong Yoo	Methods and compositions for reducing toxicity of a pharmaceutical compound
EP1112060B1 (de) *	1998-09-09	2005-12-07	ALZA Corporation	Dosierungsform mit flüssiger formulierung
DE19842753A1 (de)	1998-09-18	2000-03-23	Bayer Ag	Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
US6531152B1 (en)	1998-09-30	2003-03-11	Dexcel Pharma Technologies Ltd.	Immediate release gastrointestinal drug delivery system
US6087396A (en) *	1998-10-05	2000-07-11	Situs Corporation	Oxybutynin formulations and method of use
GB9822854D0 (en)	1998-10-21	1998-12-16	Reckitt & Colmann Prod Ltd	Improvements in or relating to organic compositions
AU765909C (en)	1998-12-17	2004-09-23	Alza Corporation	Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
KR100603168B1 (ko)	1998-12-18	2006-07-24	알자 코포레이션	투명한 경피성 니코틴 전달 장치
US6797283B1 (en)	1998-12-23	2004-09-28	Alza Corporation	Gastric retention dosage form having multiple layers
WO2000040089A1 (en) *	1999-01-05	2000-07-13	Massachusetts Eye And Ear Infirmary	Targeted transscleral controlled release drug delivery to the retina and choroid
ATE433318T1 (de)	1999-02-10	2009-06-15	Pfizer Prod Inc	Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten
US6706283B1 (en) *	1999-02-10	2004-03-16	Pfizer Inc	Controlled release by extrusion of solid amorphous dispersions of drugs
US6515028B1 (en)	1999-02-12	2003-02-04	G.D. Searle & Co.	Glucamine compounds for treating hepatitis virus infections
WO2000047198A2 (en)	1999-02-12	2000-08-17	G.D. Searle & Co.	Use of substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
US6198966B1 (en)	1999-02-26	2001-03-06	Medtronic, Inc.	Recirculating implantable drug delivery system
US8545880B2 (en) *	1999-02-26	2013-10-01	Andrx Pharmaceuticals, Llc	Controlled release oral dosage form
US6210716B1 (en)	1999-02-26	2001-04-03	Andrx Pharmaceuticals, Inc.	Controlled release bupropion formulation
US6835194B2 (en) *	1999-03-18	2004-12-28	Durect Corporation	Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US6541021B1 (en) *	1999-03-18	2003-04-01	Durect Corporation	Devices and methods for pain management
US20040121014A1 (en) *	1999-03-22	2004-06-24	Control Delivery Systems, Inc.	Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) *	1999-03-22	2001-04-17	Control Delivery Systems	Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217896B1 (en) *	1999-04-01	2001-04-17	Uab Research Foundation	Conjunctival inserts for topical delivery of medication or lubrication
US6632451B2 (en)	1999-06-04	2003-10-14	Dexcel Pharma Technologies Ltd.	Delayed total release two pulse gastrointestinal drug delivery system
US6287870B1 (en) *	1999-08-20	2001-09-11	Robert A. Levine	Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
CO5210862A1 (es)	1999-09-15	2002-10-30	Alza Corp	Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
US6387325B1 (en) *	1999-10-08	2002-05-14	Becton Dickinson & Company	Assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample
US7943162B2 (en) *	1999-10-21	2011-05-17	Alcon, Inc.	Drug delivery device
US6416777B1 (en) *	1999-10-21	2002-07-09	Alcon Universal Ltd.	Ophthalmic drug delivery device
DE60018777T2 (de)	1999-10-21	2006-02-02	Alcon Inc.	Medikamentenversorgung der sub-tenon
PT1221917E (pt)	1999-10-21	2005-04-29	Alcon Inc	Dispositivo para ministrar medicamentos
US20060153914A1 (en) *	1999-12-10	2006-07-13	Biovail Laboratories International S.R.L.	Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en)	1999-12-10	2006-09-19	Biovall Laboratories International Srl	Chronotherapeutic diltiazem formulations and the administration thereof
JP2003518487A (ja)	1999-12-23	2003-06-10	ファイザー・プロダクツ・インク	ヒドロゲル駆動型積層薬物製剤
CA2395333C (en)	1999-12-23	2009-01-13	Pfizer Products Inc.	Hydrogel-driven drug dosage form
DE19962924A1 (de)	1999-12-24	2001-07-05	Bayer Ag	Substituierte Oxazolidinone und ihre Verwendung
US6669954B2 (en)	2000-01-25	2003-12-30	John R. Crison	Controlled release of drugs
JP2004500378A (ja) *	2000-02-04	2004-01-08	ヨー、セオ、ホン	胆汁酸を含有する清浄水溶液製型の製造
AU2001236938A1 (en) *	2000-02-14	2001-08-27	Pharmacia Corporation	Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
US6464688B1 (en)	2000-02-15	2002-10-15	Microsolutions, Inc.	Osmotic pump delivery system with flexible drug compartment
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6582441B1 (en)	2000-02-24	2003-06-24	Advanced Bionics Corporation	Surgical insertion tool
US6855703B1 (en)	2000-03-10	2005-02-15	Endeavor Pharmaceuticals	Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7074803B2 (en) *	2001-03-02	2006-07-11	Durect Corporation	Opioid formulations
US7989436B2 (en)	2003-07-23	2011-08-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and pharmaceutical formulations comprising the same
US6660726B2 (en) *	2000-03-10	2003-12-09	Endeavor Pharmaceuticals	Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7459445B2 (en) *	2000-03-10	2008-12-02	Duramed Pharmaceuticals, Inc.	Estrogenic compounds and topical pharmaceutical formulations of the same
US6375972B1 (en)	2000-04-26	2002-04-23	Control Delivery Systems, Inc.	Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
CA2407154A1 (en)	2000-04-27	2001-11-01	Verion, Inc	Zero order release and temperature-controlled microcapsules and process for the preparation thereof
US6726918B1 (en)	2000-07-05	2004-04-27	Oculex Pharmaceuticals, Inc.	Methods for treating inflammation-mediated conditions of the eye
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
ES2250504T3 (es)	2000-11-29	2006-04-16	Allergan Inc.	Prevencion del rechazo de injerto en el ojo.
JP4248236B2 (ja) *	2000-11-29	2009-04-02	デュレクトコーポレイション	薬物送達装置からの送達を制御するための装置および方法
US6560471B1 (en)	2001-01-02	2003-05-06	Therasense, Inc.	Analyte monitoring device and methods of use
US7493172B2 (en) *	2001-01-30	2009-02-17	Boston Scientific Neuromodulation Corp.	Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US20060064140A1 (en) *	2001-01-30	2006-03-23	Whitehurst Todd K	Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
US20050143789A1 (en) *	2001-01-30	2005-06-30	Whitehurst Todd K.	Methods and systems for stimulating a peripheral nerve to treat chronic pain
IN190699B (de)	2001-02-02	2003-08-16	Sun Pharmaceutical Ind Ltd
US20030157166A1 (en) *	2001-03-16	2003-08-21	Chen Chih Ming	Controlled release sulfonylurea formulation
EP1397068A2 (de)	2001-04-02	2004-03-17	Therasense, Inc.	Gerät und verfahren zur blutzuckerverfolgung
US6632217B2 (en) *	2001-04-19	2003-10-14	Microsolutions, Inc.	Implantable osmotic pump
US20110104214A1 (en)	2004-04-15	2011-05-05	Purdue Pharma L.P.	Once-a-day oxycodone formulations
UA81224C2 (uk) *	2001-05-02	2007-12-25	Euro Celtic S A	Дозована форма оксикодону та її застосування
EP1387671A1 (de)	2001-05-03	2004-02-11	MASSACHUSETTS EYE & EAR INFIRMARY	Implantierbare arzneistoffverabreichungsvorrichtung und verwendung derselben
WO2002100318A2 (en)	2001-06-12	2002-12-19	Johns Hopkins University School Of Medicine	Reservoir device for intraocular drug delivery
DE10129725A1 (de) *	2001-06-20	2003-01-02	Bayer Ag	Kombinationstherapie substituierter Oxazolidinone
US20040180087A1 (en) *	2001-06-21	2004-09-16	Boyong Li	Stable controlled release pharmaceutical compositions containing pravastatin
ES2278936T3 (es)	2001-07-23	2007-08-16	Alcon, Inc.	Dispositivo de administracion de farmacos oftalmicos.
MXPA03011610A (es) *	2001-07-23	2004-07-01	Alcon Inc	Dispositivo para la administracion de farmacos oftalmicos.
US20030091634A1 (en) *	2001-09-14	2003-05-15	Pawan Seth	Delayed release tablet of venlafaxin
BR0212951A (pt) *	2001-09-28	2004-10-26	Mcneil Ppc Inc	Formas de dosagens compósitas
US20030153864A1 (en) *	2001-10-16	2003-08-14	Bernard Chaffringeon	Disposable device and method for transferring an active liquid into a body cavity
US20030185882A1 (en) *	2001-11-06	2003-10-02	Vergez Juan A.	Pharmaceutical compositions containing oxybutynin
US8329217B2 (en)	2001-11-06	2012-12-11	Osmotica Kereskedelmi Es Szolgaltato Kft	Dual controlled release dosage form
US7183321B2 (en) *	2001-12-17	2007-02-27	Bristol-Myers Squibb Company	Antidiabetic formulation and method
US20030161882A1 (en) *	2002-02-01	2003-08-28	Waterman Kenneth C.	Osmotic delivery system
TW200302748A (en) *	2002-02-01	2003-08-16	Pfizer Prod Inc	Osmotic delivery system
US9247901B2 (en)	2003-08-22	2016-02-02	Dexcom, Inc.	Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en)	2002-05-22	2009-11-03	Dexcom, Inc.	Silicone based membranes for use in implantable glucose sensors
US8364229B2 (en)	2003-07-25	2013-01-29	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7497827B2 (en)	2004-07-13	2009-03-03	Dexcom, Inc.	Transcutaneous analyte sensor
US8010174B2 (en)	2003-08-22	2011-08-30	Dexcom, Inc.	Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en)	2003-07-25	2012-09-04	Dexcom, Inc.	Systems and methods for replacing signal data artifacts in a glucose sensor data stream
EP2316468A1 (de)	2002-02-22	2011-05-04	Shire LLC	Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
US7514107B2 (en)	2002-03-21	2009-04-07	Mars, Incorporated	Treatment of diseases involving defective gap junctional communication
AU2003230805A1 (en) *	2002-04-05	2003-10-27	Penwest Pharmaceuticals Co.	Sustained release metoprolol formulations
US7125563B2 (en)	2002-04-12	2006-10-24	Dava Pharmaceuticals, Inc.	Sustained release pharmaceutical preparations and methods for producing the same
US6733526B2 (en)	2002-04-25	2004-05-11	Advanced Medical Optics, Inc.	Method of improving adherence and centering of intra-corneal implants on corneal bed
US20040010000A1 (en) *	2002-04-29	2004-01-15	Ayer Atul D.	Methods and dosage forms for controlled delivery of oxycodone
US20050106249A1 (en) *	2002-04-29	2005-05-19	Stephen Hwang	Once-a-day, oral, controlled-release, oxycodone dosage forms
AU2003217531A1 (en) *	2002-05-02	2003-11-17	Massachusetts Eye And Ear Infirmary	Ocular drug delivery systems and use thereof
US7328706B2 (en)	2002-05-06	2008-02-12	Dynamic Mouth Devices Llc	Therapeutic and protective dental device useful as an intra-oral delivery system
US8871241B2 (en) *	2002-05-07	2014-10-28	Psivida Us, Inc.	Injectable sustained release delivery devices
US7151961B1 (en) *	2002-05-24	2006-12-19	Advanced Bionics Corporation	Treatment of movement disorders by brain stimulation
CN1671358A (zh) *	2002-05-31	2005-09-21	阿尔扎公司	用于渗透传递可变剂量的羟考酮的剂型和组合物
US20040043067A1 (en) *	2002-06-19	2004-03-04	Salamone Joseph C.	Fluorosiloxane matrix controlled diffusion drug delivery systems
AR039744A1 (es) *	2002-06-26	2005-03-09	Alza Corp	Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20040005359A1 (en) *	2002-06-27	2004-01-08	Cheng Xiu Xiu	Controlled release oral dosage form
EP1534238A1 (de) *	2002-07-29	2005-06-01	ALZA Corporation	Formulierungen und dosierformen fuer die kontrollierte abgabe von topiramat
US20050232995A1 (en) *	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
US7254449B2 (en) *	2002-07-31	2007-08-07	Advanced Bionics Corp	Systems and methods for providing power to one or more implantable devices
EP1545551A4 (de)	2002-09-06	2008-10-22	Durect Corp	Abgabe von modulatoren der glutamat-vermittelten neurotransmission an das innenohr
US20060009739A1 (en) *	2002-09-06	2006-01-12	Durect Corporation	Implantable flow regulator with failsafe mode and reserve drug supply
US20050048119A1 (en) *	2002-09-20	2005-03-03	Avinash Nangia	Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
US20050051922A1 (en) *	2002-09-20	2005-03-10	Avinash Nangia	Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
EP2422775A3 (de) *	2002-09-20	2012-04-18	Alpharma, Inc.	Sequestriermitteluntereinheit und zugehörige Zusammensetzungen und Verfahren
UY28056A1 (es) *	2002-10-31	2003-12-31	Alza Corp	Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7381184B2 (en)	2002-11-05	2008-06-03	Abbott Diabetes Care Inc.	Sensor inserter assembly
GB2395126A (en)	2002-11-09	2004-05-19	Reckitt Benckiser	Volatile substance dispenser
US6893660B2 (en) *	2002-11-21	2005-05-17	Andrx Pharmaceuticals, Inc.	Stable pharmaceutical compositions without a stabilizer
US20040102476A1 (en) *	2002-11-25	2004-05-27	Chan Tai Wah	High concentration formulations of opioids and opioid derivatives
SI2218448T1 (sl)	2002-12-13	2016-01-29	Durect Corporation	Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo
AU2003303597A1 (en)	2002-12-31	2004-07-29	Therasense, Inc.	Continuous glucose monitoring system and methods of use
DE10300111A1 (de) *	2003-01-07	2004-07-15	Bayer Healthcare Ag	Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US20050048099A1 (en)	2003-01-09	2005-03-03	Allergan, Inc.	Ocular implant made by a double extrusion process
JP2006522016A (ja) *	2003-01-14	2006-09-28	アルザ・コーポレーシヨン	改変された粘度の層を用いる方法および投薬形態物
JP3811127B2 (ja) *	2003-01-30	2006-08-16	株式会社東芝	情報記録装置及び情報記録方法
JP2006517593A (ja) *	2003-02-11	2006-07-27	アルザ・コーポレーシヨン	投薬形態物の層形状修飾方法およびそのような修飾を受けさせた投薬形態物
US20060167435A1 (en) *	2003-02-18	2006-07-27	Adamis Anthony P	Transscleral drug delivery device and related methods
US6992075B2 (en) *	2003-04-04	2006-01-31	Barr Laboratories, Inc.	C(14) estrogenic compounds
WO2004091535A2 (en) *	2003-04-11	2004-10-28	Barr Laboratories, Inc.	Methods of administering estrogens and progestins
US20040213850A1 (en) *	2003-04-25	2004-10-28	Eleni Dokou	Sustained release delivery of a thrombin inhibitor
US20070083240A1 (en) *	2003-05-08	2007-04-12	Peterson David K L	Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
JP2007525188A (ja)	2003-05-16	2007-09-06	インターミューンインコーポレイテッド	合成ケモカイン受容体リガンドおよびその使用方法
US8066639B2 (en)	2003-06-10	2011-11-29	Abbott Diabetes Care Inc.	Glucose measuring device for use in personal area network
US20040253293A1 (en) *	2003-06-16	2004-12-16	Afshin Shafiee	Rate controlled release of a pharmaceutical agent in a biodegradable device
US7145125B2 (en)	2003-06-23	2006-12-05	Advanced Optical Technologies, Llc	Integrating chamber cone light using LED sources
CA2529984C (en)	2003-06-26	2012-09-25	Isa Odidi	Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
ZA200508654B (en) *	2003-07-10	2007-01-31	Alcon Inc	Ophthalmic drug delivery device
US9763609B2 (en)	2003-07-25	2017-09-19	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7761130B2 (en)	2003-07-25	2010-07-20	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
US7774145B2 (en)	2003-08-01	2010-08-10	Dexcom, Inc.	Transcutaneous analyte sensor
US20190357827A1 (en)	2003-08-01	2019-11-28	Dexcom, Inc.	Analyte sensor
US8275437B2 (en)	2003-08-01	2012-09-25	Dexcom, Inc.	Transcutaneous analyte sensor
US7591801B2 (en)	2004-02-26	2009-09-22	Dexcom, Inc.	Integrated delivery device for continuous glucose sensor
MXPA06001548A (es) *	2003-08-06	2006-09-04	Johnson & Johnson	Suministro uniforme de topiramato durante un periodo prolongado con formulaciones de dispersion.
WO2005020957A2 (en) *	2003-08-22	2005-03-10	Alza Corporation	Stepwise delivery of topiramate over prolonged period of time
US8233959B2 (en)	2003-08-22	2012-07-31	Dexcom, Inc.	Systems and methods for processing analyte sensor data
US20140121989A1 (en)	2003-08-22	2014-05-01	Dexcom, Inc.	Systems and methods for processing analyte sensor data
US7920906B2 (en)	2005-03-10	2011-04-05	Dexcom, Inc.	System and methods for processing analyte sensor data for sensor calibration
WO2005020959A2 (en) *	2003-09-02	2005-03-10	Alza Corporation	Novel drug compositions and dosage forms of topiramate
US7611728B2 (en) *	2003-09-05	2009-11-03	Supernus Pharmaceuticals, Inc.	Osmotic delivery of therapeutic compounds by solubility enhancement
AU2004275813A1 (en) *	2003-09-26	2005-04-07	Alza Corporation	Osmotic dosage forms for controlled delivery of alprazolam
WO2005030181A1 (en) *	2003-09-26	2005-04-07	Alza Corporation	Controlled release formulations of opioid and nonopioid analgesics
US20070259033A1 (en)	2003-09-26	2007-11-08	Evangeline Cruz	Controlled release formulations exhibiting an ascending rate of release
NZ546148A (en)	2003-09-26	2009-05-31	Alza Corp	Drug coating providing high drug loading and methods for providing the same
WO2005030166A1 (en) *	2003-09-26	2005-04-07	Alza Corporation	Oros push-stick for controlled delivery of active agents
US7407973B2 (en) *	2003-10-24	2008-08-05	Intermune, Inc.	Use of pirfenidone in therapeutic regimens
US20070191815A1 (en)	2004-09-13	2007-08-16	Chrono Therapeutics, Inc.	Biosynchronous transdermal drug delivery
KR20060109922A (ko) *	2003-10-31	2006-10-23	알자 코포레이션	가바펜틴 및 프리가발린의 개선된 흡수를 위한 조성물 및제형
US20050118246A1 (en) *	2003-10-31	2005-06-02	Wong Patrick S.	Dosage forms and layered deposition processes for fabricating dosage forms
US7299082B2 (en)	2003-10-31	2007-11-20	Abbott Diabetes Care, Inc.	Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD902408S1 (en)	2003-11-05	2020-11-17	Abbott Diabetes Care Inc.	Analyte sensor control unit
US20060141049A1 (en) *	2003-11-12	2006-06-29	Allergan, Inc.	Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20050101582A1 (en)	2003-11-12	2005-05-12	Allergan, Inc.	Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) *	2003-11-12	2007-09-27	Lyons Robert T	Low immunogenicity corticosteroid compositions
US9247900B2 (en)	2004-07-13	2016-02-02	Dexcom, Inc.	Analyte sensor
US8615282B2 (en)	2004-07-13	2013-12-24	Dexcom, Inc.	Analyte sensor
DE10355461A1 (de)	2003-11-27	2005-06-23	Bayer Healthcare Ag	Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
EP1689787A2 (de)	2003-11-28	2006-08-16	Eastman Chemical Company	Cellulose-mischpolymere und oxidationsverfahren
US8423114B2 (en)	2006-10-04	2013-04-16	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
EP2256493B1 (de)	2003-12-05	2014-02-26	DexCom, Inc.	Kalibrierverfahren für einen kontinuierlichen Analytsensor
US11633133B2 (en)	2003-12-05	2023-04-25	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
WO2005062829A2 (en) *	2003-12-19	2005-07-14	Advanced Bionics Corporation	Skull-mounted electrical stimulation system and method for treating patients
AU2004308973A1 (en) *	2003-12-23	2005-07-14	Alza Corporation	Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
AU2004312084A1 (en) *	2003-12-29	2005-07-21	Alza Corporation, Inc.	Novel drug compositions and dosage forms of topiramate
CA2551815A1 (en) *	2003-12-29	2005-07-21	Alza Corporation	Novel drug compositions and dosage forms
US20050175696A1 (en) *	2003-12-29	2005-08-11	David Edgren	Drug granule coatings that impart smear resistance during mechanical compression
AU2005209201B2 (en)	2004-01-20	2010-06-03	Allergan, Inc.	Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
CA2556331A1 (en)	2004-02-17	2005-09-29	Therasense, Inc.	Method and system for providing data communication in continuous glucose monitoring and management system
US8808228B2 (en)	2004-02-26	2014-08-19	Dexcom, Inc.	Integrated medicament delivery device for use with continuous analyte sensor
WO2009048462A1 (en)	2007-10-09	2009-04-16	Dexcom, Inc.	Integrated insulin delivery system with continuous glucose sensor
US20050196447A1 (en) *	2004-03-05	2005-09-08	Huang Hai Y.	Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) *	2004-03-05	2005-09-08	Hai Yong Huang	Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) *	2004-03-05	2005-09-08	Huang Hai Y.	Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) *	2004-03-05	2005-09-08	Huang Hai Y.	Polymeric compositions and dosage forms comprising the same
US20050226929A1 (en) *	2004-04-12	2005-10-13	Jianbo Xie	Controlled release opioid analgesic formulation
US8529927B2 (en) *	2004-04-30	2013-09-10	Allergan, Inc.	Alpha-2 agonist polymeric drug delivery systems
US7589057B2 (en)	2004-04-30	2009-09-15	Allergan, Inc.	Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
US8722097B2 (en)	2004-04-30	2014-05-13	Allergan, Inc.	Oil-in-water method for making polymeric implants containing a hypotensive lipid
US8119154B2 (en)	2004-04-30	2012-02-21	Allergan, Inc.	Sustained release intraocular implants and related methods
US8425929B2 (en)	2004-04-30	2013-04-23	Allergan, Inc.	Sustained release intraocular implants and methods for preventing retinal dysfunction
US7799336B2 (en)	2004-04-30	2010-09-21	Allergan, Inc.	Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244465A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Drug delivery systems and methods for treatment of an eye
US20060182783A1 (en) *	2004-04-30	2006-08-17	Allergan, Inc.	Sustained release intraocular drug delivery systems
US8591885B2 (en) *	2004-04-30	2013-11-26	Allergan, Inc.	Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20050244461A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Controlled release drug delivery systems and methods for treatment of an eye
US20050244466A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Photodynamic therapy in conjunction with intraocular implants
US20050244462A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Devices and methods for treating a mammalian eye
US20050244458A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Sustained release intraocular implants and methods for treating ocular neuropathies
US8673341B2 (en) *	2004-04-30	2014-03-18	Allergan, Inc.	Intraocular pressure reduction with intracameral bimatoprost implants
US20050244500A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Intravitreal implants in conjuction with photodynamic therapy to improve vision
US8147865B2 (en)	2004-04-30	2012-04-03	Allergan, Inc.	Steroid-containing sustained release intraocular implants and related methods
US20050244478A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Anti-excititoxic sustained release intraocular implants and related methods
US20050244471A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
US20050244469A1 (en)	2004-04-30	2005-11-03	Allergan, Inc.	Extended therapeutic effect ocular implant treatments
US7993634B2 (en)	2004-04-30	2011-08-09	Allergan, Inc.	Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8512738B2 (en) *	2004-04-30	2013-08-20	Allergan, Inc.	Biodegradable intravitreal tyrosine kinase implants
US20050244463A1 (en) *	2004-04-30	2005-11-03	Allergan, Inc.	Sustained release intraocular implants and methods for treating ocular vasculopathies
US9498457B2 (en)	2004-04-30	2016-11-22	Allergan, Inc.	Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US7771742B2 (en)	2004-04-30	2010-08-10	Allergan, Inc.	Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US20070059336A1 (en) *	2004-04-30	2007-03-15	Allergan, Inc.	Anti-angiogenic sustained release intraocular implants and related methods
US20060182781A1 (en) *	2004-04-30	2006-08-17	Allergan, Inc.	Methods for treating ocular conditions with cyclic lipid contraining microparticles
WO2005110374A1 (en) *	2004-04-30	2005-11-24	Allergan, Inc.	Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
DE102004023069A1 (de)	2004-05-11	2005-12-08	Bayer Healthcare Ag	Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US20050267555A1 (en) *	2004-05-28	2005-12-01	Marnfeldt Goran N	Engagement tool for implantable medical devices
CA2858901C (en)	2004-06-04	2024-01-16	Carolyn Anderson	Diabetes care host-client architecture and data management system
US20050287213A1 (en) *	2004-06-28	2005-12-29	Wong Patrick S	Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
US8394409B2 (en) *	2004-07-01	2013-03-12	Intellipharmaceutics Corp.	Controlled extended drug release technology
US20080027513A1 (en) *	2004-07-09	2008-01-31	Advanced Bionics Corporation	Systems And Methods For Using A Butterfly Coil To Communicate With Or Transfer Power To An Implantable Medical Device
JP2008505978A (ja) *	2004-07-12	2008-02-28	アラーガン、インコーポレイテッド	眼病用組成物および眼病治療法
US8565848B2 (en)	2004-07-13	2013-10-22	Dexcom, Inc.	Transcutaneous analyte sensor
US7783333B2 (en)	2004-07-13	2010-08-24	Dexcom, Inc.	Transcutaneous medical device with variable stiffness
US20070045902A1 (en)	2004-07-13	2007-03-01	Brauker James H	Analyte sensor
US20060016700A1 (en)	2004-07-13	2006-01-26	Dexcom, Inc.	Transcutaneous analyte sensor
US8452368B2 (en)	2004-07-13	2013-05-28	Dexcom, Inc.	Transcutaneous analyte sensor
US8452407B2 (en) *	2004-08-16	2013-05-28	Boston Scientific Neuromodulation Corporation	Methods for treating gastrointestinal disorders
US10624858B2 (en)	2004-08-23	2020-04-21	Intellipharmaceutics Corp	Controlled release composition using transition coating, and method of preparing same
WO2006026555A2 (en) *	2004-08-30	2006-03-09	Seo Hong Yoo	Neuroprotective effect of solubilized udca in focal ischemic model
US8252321B2 (en)	2004-09-13	2012-08-28	Chrono Therapeutics, Inc.	Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US8541026B2 (en) *	2004-09-24	2013-09-24	Abbvie Inc.	Sustained release formulations of opioid and nonopioid analgesics
WO2006043965A1 (en) *	2004-10-14	2006-04-27	Allergan, Inc.	Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
JP2008516977A (ja) *	2004-10-15	2008-05-22	セオホンユー	薬剤学的化合物の毒性を減少させるための方法及び組成物
ATE491456T1 (de) *	2004-11-01	2011-01-15	Seo Hong Yoo	Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
US9358393B1 (en)	2004-11-09	2016-06-07	Andres M. Lozano	Stimulation methods and systems for treating an auditory dysfunction
AR053986A1 (es)	2004-12-03	2007-05-30	Osmotica Pharmaceutical Argent	Dispositivo osmotico que contiene amantadina y una sal osmotica
US7483746B2 (en) *	2004-12-06	2009-01-27	Boston Scientific Neuromodulation Corp.	Stimulation of the stomach in response to sensed parameters to treat obesity
US20060161217A1 (en) *	2004-12-21	2006-07-20	Jaax Kristen N	Methods and systems for treating obesity
US9095713B2 (en) *	2004-12-21	2015-08-04	Allison M. Foster	Methods and systems for treating autism by decreasing neural activity within the brain
US9327069B2 (en)	2004-12-21	2016-05-03	Boston Scientific Neuromodulation Corporation	Methods and systems for treating a medical condition by promoting neural remodeling within the brain
US20070038264A1 (en) *	2004-12-21	2007-02-15	Jaax Kristen N	Methods and systems for treating autism
US20060134175A1 (en) *	2004-12-22	2006-06-22	Stephen Bartels	Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
US8515541B1 (en)	2004-12-22	2013-08-20	Boston Scientific Neuromodulation Corporation	Methods and systems for treating post-stroke disorders
CA2588692A1 (en) *	2004-12-22	2006-06-29	Alcon, Inc.	Device for ophthalmic drug delivery
US9352145B2 (en) *	2004-12-22	2016-05-31	Boston Scientific Neuromodulation Corporation	Methods and systems for treating a psychotic disorder
US20060134176A1 (en) *	2004-12-22	2006-06-22	Bausch & Lomb Incorporated	Pharmaceutical delivery system and method of use
US20060134174A1 (en) *	2004-12-22	2006-06-22	Bausch & Lomb Incorporated	Pharmaceutical delivery system and method of use
US8029441B2 (en)	2006-02-28	2011-10-04	Abbott Diabetes Care Inc.	Analyte sensor transmitter unit configuration for a data monitoring and management system
US9351669B2 (en)	2009-09-30	2016-05-31	Abbott Diabetes Care Inc.	Interconnect for on-body analyte monitoring device
US9743862B2 (en)	2011-03-31	2017-08-29	Abbott Diabetes Care Inc.	Systems and methods for transcutaneously implanting medical devices
US9398882B2 (en)	2005-09-30	2016-07-26	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte sensor and data processing device
US9636450B2 (en)	2007-02-19	2017-05-02	Udo Hoss	Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US20090105569A1 (en)	2006-04-28	2009-04-23	Abbott Diabetes Care, Inc.	Introducer Assembly and Methods of Use
US7731657B2 (en)	2005-08-30	2010-06-08	Abbott Diabetes Care Inc.	Analyte sensor introducer and methods of use
US8613703B2 (en)	2007-05-31	2013-12-24	Abbott Diabetes Care Inc.	Insertion devices and methods
US7697967B2 (en)	2005-12-28	2010-04-13	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte sensor insertion
US9572534B2 (en)	2010-06-29	2017-02-21	Abbott Diabetes Care Inc.	Devices, systems and methods for on-skin or on-body mounting of medical devices
US7883464B2 (en)	2005-09-30	2011-02-08	Abbott Diabetes Care Inc.	Integrated transmitter unit and sensor introducer mechanism and methods of use
US9788771B2 (en)	2006-10-23	2017-10-17	Abbott Diabetes Care Inc.	Variable speed sensor insertion devices and methods of use
US10226207B2 (en)	2004-12-29	2019-03-12	Abbott Diabetes Care Inc.	Sensor inserter having introducer
US8333714B2 (en)	2006-09-10	2012-12-18	Abbott Diabetes Care Inc.	Method and system for providing an integrated analyte sensor insertion device and data processing unit
US8571624B2 (en)	2004-12-29	2013-10-29	Abbott Diabetes Care Inc.	Method and apparatus for mounting a data transmission device in a communication system
US9259175B2 (en)	2006-10-23	2016-02-16	Abbott Diabetes Care, Inc.	Flexible patch for fluid delivery and monitoring body analytes
US8512243B2 (en)	2005-09-30	2013-08-20	Abbott Diabetes Care Inc.	Integrated introducer and transmitter assembly and methods of use
IL166114A0 (en) *	2005-01-03	2006-01-15	Calcident Active Ltd	Long-acting controlled-release pharmaceutical preparation for use in the oral cavity
US20060165798A1 (en) *	2005-01-27	2006-07-27	Edgren David E	Oral osmotic dosage form having a high flux membrane
EP1685841A1 (de) *	2005-01-31	2006-08-02	Bayer Health Care Aktiengesellschaft	Prophylaxe und Behandlung von thrombolischen Erkrankungen
EP1853272A1 (de) *	2005-02-03	2007-11-14	Duramed Pharmaceuticals, Inc.	Zusammensetzungen aus unkonjugierten östrogenen und anwendungsverfahren dafür
CA2596933A1 (en) *	2005-02-03	2006-08-10	Duramed Pharmaceuticals, Inc.	Devices for delivering agents to a vaginal tract
EP1690540A1 (de) *	2005-02-15	2006-08-16	Neuro3D	Zusammensetzung enthaltend Ocaperidon
US20060185665A1 (en) *	2005-02-22	2006-08-24	Bachinski Thomas J	Sauna fireplace
US20060194724A1 (en) *	2005-02-25	2006-08-31	Whitehurst Todd K	Methods and systems for nerve regeneration
US20060204548A1 (en)	2005-03-01	2006-09-14	Allergan, Inc.	Microimplants for ocular administration
US7848803B1 (en)	2005-03-14	2010-12-07	Boston Scientific Neuromodulation Corporation	Methods and systems for facilitating stimulation of one or more stimulation sites
US8423155B1 (en)	2005-03-14	2013-04-16	Boston Scientific Neuromodulation Corporation	Methods and systems for facilitating stimulation of one or more stimulation sites
US7853321B2 (en) *	2005-03-14	2010-12-14	Boston Scientific Neuromodulation Corporation	Stimulation of a stimulation site within the neck or head
US7920915B2 (en) *	2005-11-16	2011-04-05	Boston Scientific Neuromodulation Corporation	Implantable stimulator
US20060233882A1 (en) *	2005-04-15	2006-10-19	Sowden Harry S	Osmotic dosage form
JP2008536928A (ja) *	2005-04-19	2008-09-11	アルザ・コーポレーシヨン	トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
US8112240B2 (en)	2005-04-29	2012-02-07	Abbott Diabetes Care Inc.	Method and apparatus for providing leak detection in data monitoring and management systems
US7931909B2 (en) *	2005-05-10	2011-04-26	Allergan, Inc.	Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
JP2009500339A (ja) *	2005-06-29	2009-01-08	アルザ・コーポレーシヨン	浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
DE102005031577A1 (de) *	2005-07-06	2007-01-11	Bayer Healthcare Ag	Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
US9447781B2 (en) *	2005-07-22	2016-09-20	University Of Utah Research Foundation	Osmotically driven dispense pump and related components for use in high pressure applications
CN101267779A (zh)	2005-07-27	2008-09-17	福罗里达大学研究基金会有限公司	使用热休克治疗眼睛疾病
US20070031496A1 (en) *	2005-08-04	2007-02-08	Edgren David E	Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
US8778395B2 (en)	2005-08-11	2014-07-15	Andrx Labs, Llc	Diltiazem controlled release formulation and method of manufacture
US20070048347A1 (en)	2005-08-26	2007-03-01	Laura Bardach	Intra-oral device for treating obesity
EP1921980A4 (de)	2005-08-31	2010-03-10	Univ Virginia	Verbesserung der genauigkeit von kontinuierlichen glucosesensoren
US20070212397A1 (en) *	2005-09-15	2007-09-13	Roth Daniel B	Pharmaceutical delivery device and method for providing ocular treatment
US7684858B2 (en) *	2005-09-21	2010-03-23	Boston Scientific Neuromodulation Corporation	Methods and systems for placing an implanted stimulator for stimulating tissue
DE102005045518A1 (de) *	2005-09-23	2007-03-29	Bayer Healthcare Ag	2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
US8187639B2 (en) *	2005-09-27	2012-05-29	Tissue Tech, Inc.	Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
EP1933852B1 (de)	2005-09-27	2018-12-19	TissueTech, Inc.	Amnion-zubereitungen und gereinigte zusammensetzungen und anwendungsverfahren
US9521968B2 (en)	2005-09-30	2016-12-20	Abbott Diabetes Care Inc.	Analyte sensor retention mechanism and methods of use
US8880138B2 (en)	2005-09-30	2014-11-04	Abbott Diabetes Care Inc.	Device for channeling fluid and methods of use
DE102005047558A1 (de) *	2005-10-04	2008-02-07	Bayer Healthcare Ag	Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de)	2005-10-04	2007-04-05	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
RU2578602C2 (ru)	2005-10-04	2016-03-27	Байер Интеллектуэль Проперти Гмбх	Способ получения 5-хлор-n-(5s)-2-оксо-3-[4-(3-оксо-морфолинил)-фенил]-1,3-оксазолидин-5-ил}-метил)-2-тиофенкарбоксамида в модификации ii (варианты)
US20070190137A1 (en) *	2005-10-07	2007-08-16	Reyes Iran	Osmotic dosage form with controlled release and fast release aspects
PL116330U1 (en) *	2005-10-31	2007-04-02	Alza Corp	Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US7766829B2 (en)	2005-11-04	2010-08-03	Abbott Diabetes Care Inc.	Method and system for providing basal profile modification in analyte monitoring and management systems
WO2007059010A2 (en)	2005-11-14	2007-05-24	Enterprise Partners Venture Capital	Stem cell factor therapy for tissue injury
AU2006318349B2 (en)	2005-11-28	2010-08-19	Marinus Pharmaceuticals	Ganaxolone formulations and methods for the making and use thereof
PL1968594T3 (pl)	2005-11-29	2011-03-31	Glaxosmithkline Llc	Leczenie zaburzeń neowaskularyzacyjnych oka, takich jak zwyrodnienie plamki żółtej, rozszerzenie naczyń siatkówki w zespole Hippla i Lindaua, zapalenie błony naczyniowej oka i obrzęk plamki
US7729758B2 (en) *	2005-11-30	2010-06-01	Boston Scientific Neuromodulation Corporation	Magnetically coupled microstimulators
US10064828B1 (en)	2005-12-23	2018-09-04	Intellipharmaceutics Corp.	Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
EP1968432A4 (de)	2005-12-28	2009-10-21	Abbott Diabetes Care Inc	Einführung eines medizinischen gerätes
US11298058B2 (en)	2005-12-28	2022-04-12	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte sensor insertion
US7610100B2 (en) *	2005-12-30	2009-10-27	Boston Scientific Neuromodulation Corporation	Methods and systems for treating osteoarthritis
US7835803B1 (en)	2006-01-17	2010-11-16	Boston Scientific Neuromodulation Corporation	Lead assemblies with one or more switching networks
US20100172989A1 (en) *	2006-01-21	2010-07-08	Abbott Laboratories	Abuse resistant melt extruded formulation having reduced alcohol interaction
US20090317355A1 (en) *	2006-01-21	2009-12-24	Abbott Gmbh & Co. Kg,	Abuse resistant melt extruded formulation having reduced alcohol interaction
US20090022798A1 (en) *	2007-07-20	2009-01-22	Abbott Gmbh & Co. Kg	Formulations of nonopioid and confined opioid analgesics
US7736310B2 (en)	2006-01-30	2010-06-15	Abbott Diabetes Care Inc.	On-body medical device securement
US20070178138A1 (en) *	2006-02-01	2007-08-02	Allergan, Inc.	Biodegradable non-opthalmic implants and related methods
US20070196487A1 (en) *	2006-02-16	2007-08-23	Geerke Johan H	Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
US7885698B2 (en)	2006-02-28	2011-02-08	Abbott Diabetes Care Inc.	Method and system for providing continuous calibration of implantable analyte sensors
US7826879B2 (en)	2006-02-28	2010-11-02	Abbott Diabetes Care Inc.	Analyte sensors and methods of use
US8309104B2 (en)	2006-03-02	2012-11-13	Watson Pharmaceuticals, Inc.	Oral controlled release formulation for sedative and hypnotic agents
US8175710B2 (en) *	2006-03-14	2012-05-08	Boston Scientific Neuromodulation Corporation	Stimulator system with electrode array and the method of making the same
US7777641B2 (en) *	2006-03-29	2010-08-17	Advanced Bionics, Llc	Systems and methods of facilitating communication between a first and second device
US7630748B2 (en)	2006-10-25	2009-12-08	Abbott Diabetes Care Inc.	Method and system for providing analyte monitoring
US8140312B2 (en)	2007-05-14	2012-03-20	Abbott Diabetes Care Inc.	Method and system for determining analyte levels
US8583205B2 (en)	2008-03-28	2013-11-12	Abbott Diabetes Care Inc.	Analyte sensor calibration management
US7653425B2 (en)	2006-08-09	2010-01-26	Abbott Diabetes Care Inc.	Method and system for providing calibration of an analyte sensor in an analyte monitoring system
US8224415B2 (en)	2009-01-29	2012-07-17	Abbott Diabetes Care Inc.	Method and device for providing offset model based calibration for analyte sensor
US9675290B2 (en)	2012-10-30	2017-06-13	Abbott Diabetes Care Inc.	Sensitivity calibration of in vivo sensors used to measure analyte concentration
US7801582B2 (en)	2006-03-31	2010-09-21	Abbott Diabetes Care Inc.	Analyte monitoring and management system and methods therefor
US7620438B2 (en)	2006-03-31	2009-11-17	Abbott Diabetes Care Inc.	Method and system for powering an electronic device
US8219173B2 (en)	2008-09-30	2012-07-10	Abbott Diabetes Care Inc.	Optimizing analyte sensor calibration
US8346335B2 (en)	2008-03-28	2013-01-01	Abbott Diabetes Care Inc.	Analyte sensor calibration management
US8226891B2 (en)	2006-03-31	2012-07-24	Abbott Diabetes Care Inc.	Analyte monitoring devices and methods therefor
US8374668B1 (en)	2007-10-23	2013-02-12	Abbott Diabetes Care Inc.	Analyte sensor with lag compensation
US8478557B2 (en)	2009-07-31	2013-07-02	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte monitoring system calibration accuracy
US8473022B2 (en)	2008-01-31	2013-06-25	Abbott Diabetes Care Inc.	Analyte sensor with time lag compensation
US9392969B2 (en)	2008-08-31	2016-07-19	Abbott Diabetes Care Inc.	Closed loop control and signal attenuation detection
US7618369B2 (en)	2006-10-02	2009-11-17	Abbott Diabetes Care Inc.	Method and system for dynamically updating calibration parameters for an analyte sensor
EP2007360B1 (de) *	2006-04-03	2014-11-26	Isa Odidi	Abgabevorrichtung mit organosol-beschichtung und kontrollierter freisetzung
US8518926B2 (en) *	2006-04-10	2013-08-27	Knopp Neurosciences, Inc.	Compositions and methods of using (R)-pramipexole
WO2007121188A2 (en) *	2006-04-10	2007-10-25	Knopp Neurosciences, Inc.	Compositions and methods of using r(+) pramipexole
US8747897B2 (en)	2006-04-27	2014-06-10	Supernus Pharmaceuticals, Inc.	Osmotic drug delivery system
US9011930B2 (en) *	2006-05-01	2015-04-21	Zycal Bioceuticals Healthcare Company, Inc.	Nutritional supplement and use thereof
US20070260203A1 (en) *	2006-05-04	2007-11-08	Allergan, Inc.	Vasoactive agent intraocular implant
US10960077B2 (en)	2006-05-12	2021-03-30	Intellipharmaceutics Corp.	Abuse and alcohol resistant drug composition
CN101448498B (zh)	2006-05-16	2011-04-27	诺普神经科学股份有限公司	R(+)和s(-)普拉克索的组合物以及使用该组合物的方法
WO2007143225A2 (en)	2006-06-07	2007-12-13	Abbott Diabetes Care, Inc.	Analyte monitoring system and method
CA2655835C (en) *	2006-06-19	2015-07-21	Alpharma, Inc.	Abuse-resistant pharmaceutical compositions of opioid agonists
US20070298073A1 (en) *	2006-06-23	2007-12-27	Allergan, Inc.	Steroid-containing sustained release intraocular implants and related methods
US8802128B2 (en)	2006-06-23	2014-08-12	Allergan, Inc.	Steroid-containing sustained release intraocular implants and related methods
US8504163B1 (en)	2006-06-30	2013-08-06	Boston Scientific Neuromodulation Corporation	Cranially mounted stimulation systems and methods
US8401654B1 (en)	2006-06-30	2013-03-19	Boston Scientific Neuromodulation Corporation	Methods and systems for treating one or more effects of deafferentation
EP2041214A4 (de)	2006-07-10	2009-07-08	Medipacs Inc	Superelastisches epoxidhydrogel
WO2008021368A2 (en)	2006-08-11	2008-02-21	The Johns Hopkins University	Compositions and methods for neuroprotection
CA2666814A1 (en) *	2006-08-21	2008-05-29	United Therapeutics Corporation	Combination therapy for treatment of viral infections
EP2201840B1 (de)	2006-09-22	2011-11-02	Pharmacyclics, Inc.	Hemmer der Bruton-Tyrosinkinase
US7445528B1 (en)	2006-09-29	2008-11-04	Boston Scientific Neuromodulation Corporation	Connector assemblies
BRPI0718119A2 (pt)	2006-10-26	2014-07-08	Abbott Diabetes Care Inc	Métodos, sistemas e programas de computador para a detecção em tempo real do declínio de sensibilidade em sensores de analito
US7347746B1 (en)	2006-10-27	2008-03-25	Boston Scientific Neuromodulation Corporation	Receptacle connector assembly
DE102006051625A1 (de) *	2006-11-02	2008-05-08	Bayer Materialscience Ag	Kombinationstherapie substituierter Oxazolidinone
US8586556B2 (en)	2006-11-03	2013-11-19	Allergan, Inc.	Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules
WO2008070479A2 (en)	2006-12-01	2008-06-12	Allergan, Inc.	Method for determining optimum intraocular locations for drug delivery systems
US8969415B2 (en)	2006-12-01	2015-03-03	Allergan, Inc.	Intraocular drug delivery systems
US8524695B2 (en) *	2006-12-14	2013-09-03	Knopp Neurosciences, Inc.	Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
US8846073B2 (en)	2006-12-19	2014-09-30	Allergan, Inc.	Low temperature processes for making cyclic lipid implants for intraocular use
EP2119442A4 (de)	2006-12-28	2010-12-15	Astellas Pharma Inc	Pharmazeutische zusammensetzung von tacrolimus mit verzögerter freisetzung
US20080176955A1 (en) *	2007-01-16	2008-07-24	Victory Pharma, Inc.	Combined administration of benzonatate and guaifenesin
US8524749B2 (en) *	2007-02-09	2013-09-03	Alza Corporation	Controlled release compositions of tizanidine
US20080199894A1 (en)	2007-02-15	2008-08-21	Abbott Diabetes Care, Inc.	Device and method for automatic data acquisition and/or detection
US8121857B2 (en)	2007-02-15	2012-02-21	Abbott Diabetes Care Inc.	Device and method for automatic data acquisition and/or detection
US8732188B2 (en)	2007-02-18	2014-05-20	Abbott Diabetes Care Inc.	Method and system for providing contextual based medication dosage determination
US8930203B2 (en)	2007-02-18	2015-01-06	Abbott Diabetes Care Inc.	Multi-function analyte test device and methods therefor
US8123686B2 (en)	2007-03-01	2012-02-28	Abbott Diabetes Care Inc.	Method and apparatus for providing rolling data in communication systems
US8519148B2 (en) *	2007-03-14	2013-08-27	Knopp Neurosciences, Inc.	Synthesis of chirally purified substituted benzothiazole diamines
US8642067B2 (en)	2007-04-02	2014-02-04	Allergen, Inc.	Methods and compositions for intraocular administration to treat ocular conditions
WO2008130898A1 (en)	2007-04-14	2008-10-30	Abbott Diabetes Care, Inc.	Method and apparatus for providing data processing and control in medical communication system
WO2008130895A2 (en)	2007-04-14	2008-10-30	Abbott Diabetes Care, Inc.	Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
US10111608B2 (en)	2007-04-14	2018-10-30	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in medical communication system
ES2461090T3 (es)	2007-04-14	2014-05-16	Abbott Diabetes Care Inc.	Procedimiento y aparato para proporcionar tratamiento y control de datos en un sistema de comunicación médica
WO2008130897A2 (en)	2007-04-14	2008-10-30	Abbott Diabetes Care, Inc.	Method and apparatus for providing data processing and control in medical communication system
WO2008128210A1 (en)	2007-04-14	2008-10-23	Abbott Diabetes Care, Inc.	Method and apparatus for providing data processing and control in medical communication system
US7911053B2 (en) *	2007-04-19	2011-03-22	Marvell World Trade Ltd.	Semiconductor packaging with internal wiring bus
US8461985B2 (en)	2007-05-08	2013-06-11	Abbott Diabetes Care Inc.	Analyte monitoring system and methods
US8456301B2 (en)	2007-05-08	2013-06-04	Abbott Diabetes Care Inc.	Analyte monitoring system and methods
US7928850B2 (en)	2007-05-08	2011-04-19	Abbott Diabetes Care Inc.	Analyte monitoring system and methods
US8665091B2 (en)	2007-05-08	2014-03-04	Abbott Diabetes Care Inc.	Method and device for determining elapsed sensor life
US8260558B2 (en)	2007-05-14	2012-09-04	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en)	2007-05-14	2012-08-07	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en)	2007-05-14	2013-12-03	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en)	2007-05-14	2012-01-24	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en)	2007-05-14	2018-06-19	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en)	2007-05-14	2013-05-21	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en)	2007-05-14	2015-09-08	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US7996158B2 (en)	2007-05-14	2011-08-09	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en)	2007-05-14	2013-10-15	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US20200037874A1 (en)	2007-05-18	2020-02-06	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20080306434A1 (en)	2007-06-08	2008-12-11	Dexcom, Inc.	Integrated medicament delivery device for use with continuous analyte sensor
JP2010531169A (ja)	2007-06-21	2010-09-24	アボットダイアベティスケアインコーポレイテッド	健康監視装置
WO2008157820A1 (en)	2007-06-21	2008-12-24	Abbott Diabetes Care, Inc.	Health management devices and methods
US8160900B2 (en)	2007-06-29	2012-04-17	Abbott Diabetes Care Inc.	Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
US8834366B2 (en)	2007-07-31	2014-09-16	Abbott Diabetes Care Inc.	Method and apparatus for providing analyte sensor calibration
US7768386B2 (en)	2007-07-31	2010-08-03	Abbott Diabetes Care Inc.	Method and apparatus for providing data processing and control in a medical communication system
US8748648B2 (en) *	2007-09-06	2014-06-10	Nektar Therapeutics	Oligomer-calcium channel blocker conjugates
CN101854933A (zh)	2007-09-10	2010-10-06	钙医学公司	调节细胞内钙的化合物
US20090088681A1 (en) *	2007-10-02	2009-04-02	Mcintyre Jon T	Device and method for the treatment of intra-abdominal disease
TWI498136B (zh) *	2007-10-09	2015-09-01	Alcon Res Ltd	用於遞送速率及溫度相依性物質至眼睛的注射器及其製備方法
TWI451862B (zh) *	2007-10-09	2014-09-11	Alcon Res Ltd	用於眼睛注射的熱係數驅動藥丸尺寸
US8216138B1 (en)	2007-10-23	2012-07-10	Abbott Diabetes Care Inc.	Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8409093B2 (en)	2007-10-23	2013-04-02	Abbott Diabetes Care Inc.	Assessing measures of glycemic variability
US8377031B2 (en)	2007-10-23	2013-02-19	Abbott Diabetes Care Inc.	Closed loop control system with safety parameters and methods
EP2227635A2 (de) *	2007-12-03	2010-09-15	Medipacs, Inc.	Fluiddosiervorrichtung
CA2706931C (en)	2007-12-06	2015-05-12	Durect Corporation	Oral pharmaceutical dosage forms
US8623418B2 (en)	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
US20100151014A1 (en) *	2008-12-16	2010-06-17	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
US20090164239A1 (en)	2007-12-19	2009-06-25	Abbott Diabetes Care, Inc.	Dynamic Display Of Glucose Information
US9226907B2 (en)	2008-02-01	2016-01-05	Abbvie Inc.	Extended release hydrocodone acetaminophen and related methods and uses thereof
KR20100136967A (ko) *	2008-02-15	2010-12-29	썬 파마 어드밴스트 리서치 컴패니 리미티드	파열 효과가 감소된 방출 제어 경구 정제
EP2262543B1 (de)	2008-04-10	2015-07-08	Abbott Diabetes Care Inc.	Verfahren und system zur sterilisierung eines analytsensors
US8591410B2 (en)	2008-05-30	2013-11-26	Abbott Diabetes Care Inc.	Method and apparatus for providing glycemic control
US7826382B2 (en)	2008-05-30	2010-11-02	Abbott Diabetes Care Inc.	Close proximity communication device and methods
US8924159B2 (en)	2008-05-30	2014-12-30	Abbott Diabetes Care Inc.	Method and apparatus for providing glycemic control
US8876755B2 (en)	2008-07-14	2014-11-04	Abbott Diabetes Care Inc.	Closed loop control system interface and methods
CN102186350A (zh)	2008-08-19	2011-09-14	诺普神经科学股份有限公司	使用(r)-普拉克索的组合物与方法
EP2321303B1 (de)	2008-08-27	2019-11-27	Calcimedica, Inc.	Verbindungen als modulatoren von intrazellulärem calcium
US8734422B2 (en)	2008-08-31	2014-05-27	Abbott Diabetes Care Inc.	Closed loop control with improved alarm functions
US20100057040A1 (en)	2008-08-31	2010-03-04	Abbott Diabetes Care, Inc.	Robust Closed Loop Control And Methods
US8622988B2 (en)	2008-08-31	2014-01-07	Abbott Diabetes Care Inc.	Variable rate closed loop control and methods
US9943644B2 (en)	2008-08-31	2018-04-17	Abbott Diabetes Care Inc.	Closed loop control with reference measurement and methods thereof
US8986208B2 (en)	2008-09-30	2015-03-24	Abbott Diabetes Care Inc.	Analyte sensor sensitivity attenuation mitigation
EP3025727A1 (de)	2008-10-02	2016-06-01	The J. David Gladstone Institutes	Verfahren zur behandlung von lebererkrankungen
US20100104654A1 (en) *	2008-10-27	2010-04-29	Allergan, Inc.	Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US20100260844A1 (en)	2008-11-03	2010-10-14	Scicinski Jan J	Oral pharmaceutical dosage forms
US9326707B2 (en)	2008-11-10	2016-05-03	Abbott Diabetes Care Inc.	Alarm characterization for analyte monitoring devices and systems
US9095506B2 (en) *	2008-11-17	2015-08-04	Allergan, Inc.	Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
DE102008059206A1 (de)	2008-11-27	2010-06-10	Bayer Schering Pharma Aktiengesellschaft	Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
US8623395B2 (en)	2010-01-29	2014-01-07	Forsight Vision4, Inc.	Implantable therapeutic device
US8399006B2 (en)	2009-01-29	2013-03-19	Forsight Vision4, Inc.	Posterior segment drug delivery
US8103456B2 (en)	2009-01-29	2012-01-24	Abbott Diabetes Care Inc.	Method and device for early signal attenuation detection using blood glucose measurements
US9402544B2 (en)	2009-02-03	2016-08-02	Abbott Diabetes Care Inc.	Analyte sensor and apparatus for insertion of the sensor
US20100204325A1 (en)	2009-02-11	2010-08-12	Allergan, Inc.	Valproic acid drug delivery systems and intraocular therapeutic uses thereof
CN102448458B (zh)	2009-03-18	2015-07-22	小利兰·斯坦福大学理事会	治疗黄病毒科病毒感染的方法和组合物
US8497777B2 (en)	2009-04-15	2013-07-30	Abbott Diabetes Care Inc.	Analyte monitoring system having an alert
ES2559029T3 (es)	2009-04-24	2016-02-10	Tissue Tech, Inc.	Composiciones que contienen al complejo HC.HA y metodos de uso de las mismas
US9226701B2 (en)	2009-04-28	2016-01-05	Abbott Diabetes Care Inc.	Error detection in critical repeating data in a wireless sensor system
EP2425209A4 (de)	2009-04-29	2013-01-09	Abbott Diabetes Care Inc	Verfahren und system für die echtzeit-kalibrierung eines analytsensors mit rückwirkender füllung
US8368556B2 (en)	2009-04-29	2013-02-05	Abbott Diabetes Care Inc.	Method and system for providing data communication in continuous glucose monitoring and management system
US20100278897A1 (en) *	2009-05-01	2010-11-04	Allergan, Inc.	Intraocular bioactive agent delivery system with molecular partitioning system
US8632511B2 (en) *	2009-05-06	2014-01-21	Alcon Research, Ltd.	Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
WO2010138856A1 (en)	2009-05-29	2010-12-02	Abbott Diabetes Care Inc.	Medical device antenna systems having external antenna configurations
US8956654B2 (en)	2009-06-02	2015-02-17	Dow Global Technologies Llc	Sustained release dosage form
IN2012DN00352A (de)	2009-06-16	2015-08-21	Bikam Pharmaceuticals Inc
CA2765876A1 (en) *	2009-06-19	2010-12-23	Knopp Neurosciences, Inc.	Compositions and methods for treating amyotrophic lateral sclerosis
US8613892B2 (en)	2009-06-30	2013-12-24	Abbott Diabetes Care Inc.	Analyte meter with a moveable head and methods of using the same
EP4309580A3 (de)	2009-07-23	2024-02-28	Abbott Diabetes Care Inc.	System zur kontinuierlichen analytmessung
CN102573813B (zh) *	2009-08-18	2013-11-06	国立大学法人东北大学	持续药物传递***
EP3001194B1 (de)	2009-08-31	2019-04-17	Abbott Diabetes Care, Inc.	Medizinische vorrichtungen und verfahren
WO2011026147A1 (en)	2009-08-31	2011-03-03	Abbott Diabetes Care Inc.	Analyte signal processing device and methods
EP2473099A4 (de)	2009-08-31	2015-01-14	Abbott Diabetes Care Inc	Analytüberwachungssystem und -verfahren zur leistungs- und rauschverwaltung
US8514086B2 (en)	2009-08-31	2013-08-20	Abbott Diabetes Care Inc.	Displays for a medical device
WO2011032011A1 (en)	2009-09-10	2011-03-17	Medipacs, Inc.	Low profile actuator and improved method of caregiver controlled administration of therapeutics
DE102009042855A1 (de) *	2009-09-24	2011-03-31	Pfenning Elektroanlagen Gmbh	Portalhubwagen zum Einsatz in Containerterminals und für allgemeine Transportaufgaben
EP2482720A4 (de)	2009-09-29	2014-04-23	Abbott Diabetes Care Inc	Verfahren und vorrichtung zur bereitstellung einer benachrichtigungsfunktion in analytüberwachungssystemen
US20120232102A1 (en)	2009-09-30	2012-09-13	Chun-Fang Xu	Methods Of Administration And Treatment
US7718662B1 (en)	2009-10-12	2010-05-18	Pharmacyclics, Inc.	Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
US8185181B2 (en)	2009-10-30	2012-05-22	Abbott Diabetes Care Inc.	Method and apparatus for detecting false hypoglycemic conditions
KR101769637B1 (ko)	2009-11-09	2017-08-18	알러간, 인코포레이티드	모발 성장을 촉진하기 위한 조성물 및 방법
US20120245505A1 (en)	2009-12-16	2012-09-27	Robinson Michael R	Intracameral devices for sustained delivery
US8177747B2 (en) *	2009-12-22	2012-05-15	Alcon Research, Ltd.	Method and apparatus for drug delivery
CN102740830A (zh) *	2009-12-23	2012-10-17	普西维达公司	缓释递送装置
US20110172639A1 (en) *	2010-01-08	2011-07-14	Ratio, Inc.	Device and method for delivery of microneedle to desired depth within the skin
US20110172609A1 (en) *	2010-01-08	2011-07-14	Ratio, Inc.	Microneedle component assembly for drug delivery device
US20110172637A1 (en) *	2010-01-08	2011-07-14	Ratio, Inc.	Drug delivery device including tissue support structure
US20110172645A1 (en) *	2010-01-08	2011-07-14	Ratio, Inc.	Wearable drug delivery device including integrated pumping and activation elements
US9500186B2 (en)	2010-02-01	2016-11-22	Medipacs, Inc.	High surface area polymer actuator with gas mitigating components
USD924406S1 (en)	2010-02-01	2021-07-06	Abbott Diabetes Care Inc.	Analyte sensor inserter
WO2011112753A1 (en)	2010-03-10	2011-09-15	Abbott Diabetes Care Inc.	Systems, devices and methods for managing glucose levels
CA3135001A1 (en)	2010-03-24	2011-09-29	Abbott Diabetes Care Inc.	Medical device inserters and processes of inserting and using medical devices
JP5849947B2 (ja)	2010-03-29	2016-02-03	アステラス製薬株式会社	放出制御医薬組成物
EP2558866B1 (de)	2010-04-15	2016-08-17	Tracon Pharmaceuticals, Inc.	Potenzierung einer antikrebs-wirkung durch eine kombinationstherapie mit ber-pfad-hemmern
AU2011248579A1 (en)	2010-04-27	2012-11-29	Calcimedica, Inc.	Compounds that modulate intracellular calcium
ES2591004T3 (es)	2010-04-27	2016-11-24	Calcimedica, Inc.	Compuestos moduladores del calcio intracelular
MY191929A (en)	2010-06-03	2022-07-18	Pharmacyclics Llc	The use of inhibitors of bruton's tyrosine kinase (btk)
US8635046B2 (en)	2010-06-23	2014-01-21	Abbott Diabetes Care Inc.	Method and system for evaluating analyte sensor response characteristics
US11064921B2 (en)	2010-06-29	2021-07-20	Abbott Diabetes Care Inc.	Devices, systems and methods for on-skin or on-body mounting of medical devices
US10092229B2 (en)	2010-06-29	2018-10-09	Abbott Diabetes Care Inc.	Calibration of analyte measurement system
US9492315B2 (en)	2010-08-05	2016-11-15	Forsight Vision4, Inc.	Implantable therapeutic device
JP6111194B2 (ja)	2010-08-05	2017-04-05	フォーサイト・ビジョンフォー・インコーポレーテッド	組み合わせ薬物送達方法および装置
US9033911B2 (en)	2010-08-05	2015-05-19	Forsight Vision4, Inc.	Injector apparatus and method for drug delivery
CN103180316A (zh)	2010-08-27	2013-06-26	钙医学公司	调节细胞内钙的化合物
EP2624745A4 (de)	2010-10-07	2018-05-23	Abbott Diabetes Care, Inc.	Analytüberwachungsvorrichtungen und -verfahren
US8668675B2 (en)	2010-11-03	2014-03-11	Flugen, Inc.	Wearable drug delivery device having spring drive and sliding actuation mechanism
US20140031769A1 (en)	2010-11-19	2014-01-30	Forsight Vision4, Inc.	Therapeutic agent formulations for implanted devices
US8518440B2 (en)	2010-12-21	2013-08-27	Confluent Surgical, Inc.	Biodegradable osmotic pump implant for drug delivery
HUE026715T2 (en)	2011-01-20	2016-07-28	Bionevia Pharmaceuticals Inc	Modified release pharmaceutical composition comprising Epalrestat or a derivative thereof and methods of their use
US8801768B2 (en) *	2011-01-21	2014-08-12	Endologix, Inc.	Graft systems having semi-permeable filling structures and methods for their use
CN103619255B (zh)	2011-02-28	2016-11-02	雅培糖尿病护理公司	与分析物监测装置关联的装置、***和方法以及结合了它们的装置
US10136845B2 (en)	2011-02-28	2018-11-27	Abbott Diabetes Care Inc.	Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
DE102011007272A1 (de)	2011-04-13	2012-10-18	Bayer Pharma Aktiengesellschaft	Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
JP6141827B2 (ja)	2011-04-15	2017-06-07	デックスコム・インコーポレーテッド	検体を測定するシステムの作動方法及び該方法を実施するべく構成されたセンサシステム
WO2012149486A1 (en)	2011-04-28	2012-11-01	Tissuetech, Inc.	Methods of modulating bone remodeling
EP2717888B1 (de)	2011-06-10	2020-09-09	Tissuetech, Inc.	Verfahren zur verarbeitung fötaler gewebesubstrate
AU2012271728B2 (en)	2011-06-14	2016-10-20	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
WO2012175698A1 (en)	2011-06-23	2012-12-27	Université Libre de Bruxelles	Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease
US10398592B2 (en)	2011-06-28	2019-09-03	Forsight Vision4, Inc.	Diagnostic methods and apparatus
WO2013006643A1 (en) *	2011-07-06	2013-01-10	The Parkinson's Institute	Compositions and methods for treatment of symptoms in parkinson's disease patients
EP2739252A4 (de)	2011-08-05	2015-08-12	Forsight Vision4 Inc	Abgabe kleiner moleküle über eine implantierbare therapeutische vorrichtung
WO2013033636A2 (en)	2011-09-01	2013-03-07	University Of Southern California	Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same
ES2627820T3 (es)	2011-09-13	2017-07-31	Pharmacyclics, Inc.	Formulaciones de inhibidor de histona desacetilasa en combinación con bendamustina y usos de las mismas
PT2755600T (pt)	2011-09-16	2021-04-19	Forsight Vision4 Inc	Aparelhos de troca de fluidos
AU2012325341B2 (en)	2011-10-19	2017-01-05	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
WO2013066849A1 (en)	2011-10-31	2013-05-10	Abbott Diabetes Care Inc.	Model based variable risk false glucose threshold alarm prevention mechanism
US9069536B2 (en)	2011-10-31	2015-06-30	Abbott Diabetes Care Inc.	Electronic devices having integrated reset systems and methods thereof
AU2012335830B2 (en)	2011-11-07	2017-05-04	Abbott Diabetes Care Inc.	Analyte monitoring device and methods
US8710993B2 (en)	2011-11-23	2014-04-29	Abbott Diabetes Care Inc.	Mitigating single point failure of devices in an analyte monitoring system and methods thereof
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
EP3936133A1 (de)	2011-11-23	2022-01-12	TherapeuticsMD, Inc.	Natürliche kombinationshormonersatzformulierungen und therapien
US9317656B2 (en)	2011-11-23	2016-04-19	Abbott Diabetes Care Inc.	Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
WO2013078426A2 (en)	2011-11-25	2013-05-30	Abbott Diabetes Care Inc.	Analyte monitoring system and methods of use
EP2785346A4 (de)	2011-11-30	2015-04-29	Bikam Pharmaceuticals Inc	Opsinbindende liganden, zusammensetzungen damit und anwendungsverfahren dafür
AU2012346537A1 (en)	2011-12-01	2014-07-17	Bikam Pharmaceuticals, Inc.	Opsin-binding ligands, compositions and methods of use
MX349036B (es)	2011-12-06	2017-07-07	Univ Leland Stanford Junior	Metodos y composiciones para tratar enfermedades virales.
CA3118810A1 (en)	2011-12-11	2013-06-20	Abbott Diabetes Care Inc.	Analyte sensor devices, connections, and methods
US9512096B2 (en)	2011-12-22	2016-12-06	Knopp Biosciences, LLP	Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US8377946B1 (en)	2011-12-30	2013-02-19	Pharmacyclics, Inc.	Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
CN104159581B (zh)	2012-01-06	2017-09-01	阿比德治疗公司	氨基甲酸酯化合物及其制备和使用方法
WO2013116061A1 (en)	2012-02-03	2013-08-08	Forsight Vision4, Inc.	Insertion and removal methods and apparatus for therapeutic devices
ES2652136T3 (es)	2012-02-16	2018-01-31	Atyr Pharma, Inc.	Histidil-tRNA sintetasas para tratar enfermedades autoinmunitarias e inflamatorias
EP2847249A4 (de)	2012-03-14	2016-12-28	Medipacs Inc	Intelligente polymermaterialien mit überschüssigen reaktiven molekülen
JP6231553B2 (ja)	2012-05-07	2017-11-15	バイエルファーマアクチエンゲゼルシャフト	ニフェジピンおよびカンデサルタン・シレキセチルを含む医薬投与形を製造する方法
TWI662964B (zh)	2012-06-04	2019-06-21	美商製藥有限責任公司	布魯頓氏酪胺酸激酶抑制劑之結晶形式
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
UY34856A (es)	2012-07-03	2013-12-31	Bayer Pharma AG	Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
KR102236805B1 (ko)	2012-07-11	2021-04-05	티슈테크, 인코포레이티드	Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
EP2890297B1 (de)	2012-08-30	2018-04-11	Abbott Diabetes Care, Inc.	Ausfallerkennung bei kontinuierlichen analytüberwachungsdaten bei datenabweichungen
US9968306B2 (en)	2012-09-17	2018-05-15	Abbott Diabetes Care Inc.	Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
WO2014052136A1 (en)	2012-09-26	2014-04-03	Abbott Diabetes Care Inc.	Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
WO2014052914A1 (en)	2012-09-28	2014-04-03	University Of Washington Through Its Center For Commercialization	Compounds and methods for preventing, treating and/or protecting against sensory hair cell death
US9717741B2 (en)	2012-10-11	2017-08-01	Anaplasi Pharmaceuticals Llc	Method and compositions for treating psoriasis
WO2014058427A1 (en)	2012-10-11	2014-04-17	Anaplasi Pharmaceuticals Llc	Method and compositions for treating psoriasis
US9512116B2 (en)	2012-10-12	2016-12-06	Calcimedica, Inc.	Compounds that modulate intracellular calcium
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
GB2510826B (en)	2013-02-13	2015-09-02	Animax Ltd	Improvements in or relating to release of a beneficial substance from a bolus
KR20150119254A (ko)	2013-02-15	2015-10-23	알러간, 인코포레이티드	지속된 약물 전달 임플란트
US9662313B2 (en)	2013-02-28	2017-05-30	Knopp Biosciences Llc	Compositions and methods for treating amyotrophic lateral sclerosis in responders
EP2968113B8 (de)	2013-03-14	2020-10-28	Forsight Vision4, Inc.	Systeme zur verzögerten intraokularen abgabe schwerlöslicher verbindungen aus einem implantat mit einem portabgabesystem
US10433773B1 (en)	2013-03-15	2019-10-08	Abbott Diabetes Care Inc.	Noise rejection methods and apparatus for sparsely sampled analyte sensor data
AU2014233453A1 (en)	2013-03-15	2015-10-01	Durect Corporation	Compositions with a rheological modifier to reduce dissolution variability
US9474475B1 (en)	2013-03-15	2016-10-25	Abbott Diabetes Care Inc.	Multi-rate analyte sensor data collection with sample rate configurable signal processing
WO2014152034A1 (en)	2013-03-15	2014-09-25	Abbott Diabetes Care Inc.	Sensor fault detection using analyte sensor data pattern comparison
ES2972168T3 (es)	2013-03-28	2024-06-11	Forsight Vision4 Inc	Implante oftálmico para administración de sustancias terapéuticas
EP3838271A1 (de)	2013-07-12	2021-06-23	Knopp Biosciences LLC	Behandlung eines erhöhten spiegels von eosinophilen und/oder basophilen
US9468630B2 (en)	2013-07-12	2016-10-18	Knopp Biosciences Llc	Compositions and methods for treating conditions related to increased eosinophils
CA2921378A1 (en)	2013-08-13	2015-02-19	Knopp Biosciences Llc	Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
DK3033081T3 (da)	2013-08-13	2021-05-31	Knopp Biosciences Llc	Sammensætninger og fremgangsmåder til behandling af kronisk urticaria
US9611263B2 (en)	2013-10-08	2017-04-04	Calcimedica, Inc.	Compounds that modulate intracellular calcium
WO2015084998A1 (en)	2013-12-05	2015-06-11	Pharmacyclics, Inc.	Inhibitors of bruton's tyrosine kinase
AU2014374361B9 (en)	2013-12-31	2019-07-04	Abbott Diabetes Care Inc.	Self-powered analyte sensor and devices using the same
EP3865063A1 (de)	2014-03-30	2021-08-18	Abbott Diabetes Care, Inc.	Verfahren und vorrichtung zur bestimmung des starts einer mahlzeit und von spitzenwertereignissen in analytüberwachungssystemen
WO2015164213A1 (en)	2014-04-23	2015-10-29	The Research Foundation For The State University Of New York	A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
CA2947767A1 (en)	2014-05-22	2015-11-26	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
TW201603818A (zh)	2014-06-03	2016-02-01	組織科技股份有限公司	組成物及方法
CA2910865C (en)	2014-07-15	2016-11-29	Isa Odidi	Compositions and methods for reducing overdose
US10258503B2 (en)	2014-07-15	2019-04-16	Forsight Vision4, Inc.	Ocular implant delivery device and method
WO2016016770A1 (en)	2014-07-26	2016-02-04	Wockhardt Limited	A novel modified release pharmaceutical composition of sitagliptin or pharmaceutically acceptable salt thereof
MY182793A (en)	2014-08-08	2021-02-05	Forsight Vision4 Inc	Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
US9839644B2 (en)	2014-09-09	2017-12-12	ARKAY Therapeutics, LLC	Formulations and methods for treatment of metabolic syndrome
CA2967330A1 (en)	2014-11-10	2016-05-19	Forsight Vision4, Inc.	Expandable drug delivery devices and methods of use
US9359316B1 (en)	2014-11-25	2016-06-07	Concentric Analgesics, Inc.	Prodrugs of phenolic TRPV1 agonists
AU2016211330A1 (en)	2015-01-28	2017-08-03	Chrono Therapeutics Inc.	Drug delivery methods and systems
US10399994B2 (en)	2015-02-06	2019-09-03	University Of Washington	Compounds and methods for preventing or treating sensory hair cell death
US10227333B2 (en)	2015-02-11	2019-03-12	Curtana Pharmaceuticals, Inc.	Inhibition of OLIG2 activity
WO2016132217A1 (en)	2015-02-20	2016-08-25	Osmotica Kereskedelmi Es Szolgaltato Kft	Method of improving gaba-b receptor agonist therapy
US20160243288A1 (en)	2015-02-23	2016-08-25	Tissuetech, Inc.	Apparatuses and methods for treating ophthalmic diseases and disorders
MX2017011018A (es)	2015-02-27	2018-01-18	Curtana Pharmaceuticals Inc	Inhibicion de la actividad de olig2.
TWI810588B (zh)	2015-03-03	2023-08-01	美商製藥公司	布魯東氏(bruton’s)酪胺酸激酶抑制劑之醫藥調配物
AU2016228779A1 (en)	2015-03-12	2017-09-07	Chrono Therapeutics Inc.	Craving input and support system
MA41828A (fr)	2015-03-27	2018-01-30	Pharmacyclics Llc	Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton
MA41827A (fr)	2015-03-27	2018-01-30	Pharmacyclics Llc	Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton
US10575976B2 (en)	2015-04-30	2020-03-03	Dynamic Mouth Devices, L.L.C.	Method and apparatus for weight management utilizing an intra-oral device
KR20180004263A (ko)	2015-05-11	2018-01-10	어바이드 테라퓨틱스, 인크.	염증 또는 신경병성 통증의 치료 방법
US10213139B2 (en)	2015-05-14	2019-02-26	Abbott Diabetes Care Inc.	Systems, devices, and methods for assembling an applicator and sensor control device
WO2016183493A1 (en)	2015-05-14	2016-11-17	Abbott Diabetes Care Inc.	Compact medical device inserters and related systems and methods
EP3297645A4 (de)	2015-05-20	2018-12-12	Tissuetech, Inc.	Zusammensetzungen und verfahren zur verhinderung der proliferation und des epithelial-mesenchymalen übergangs von epithelzellen
CN108024765B (zh)	2015-07-10	2021-06-11	雅培糖尿病护理公司	对于生理参数进行动态葡萄糖曲线响应的***、装置和方法
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
AU2016303688B2 (en)	2015-07-31	2023-06-15	Research Institute At Nationwide Children's Hospital	Peptides and antibodies for the removal of biofilms
WO2017040617A1 (en)	2015-08-31	2017-03-09	Pharmacyclics Llc	Btk inhibitor combinations for treating multiple myeloma
EP3365027B1 (de)	2015-10-14	2022-03-30	Research Institute at Nationwide Children's Hospital	Hu-spezifische antikörper und deren verwendeng zur hemmung von biofilm
MX2018006234A (es)	2015-11-20	2018-08-14	Forsight Vision4 Inc	Estructuras porosas para dispositivos de suministro de medicamentos de liberacion prolongada.
US10975149B2 (en)	2015-12-16	2021-04-13	The Walter And Eliza Hall Institute Of Medical Research	Inhibition of cytokine-induced SH2 protein in NK cells
MX2018008772A (es)	2016-01-19	2018-11-09	Janssen Pharmaceutica Nv	Formulaciones/composiciones que comprenden un inhibidor de btk.
CN108472259A (zh)	2016-01-19	2018-08-31	詹森药业有限公司	包含btk抑制剂的配制品/组合物
TW201733600A (zh)	2016-01-29	2017-10-01	帝聖工業公司	胎兒扶持組織物及使用方法
WO2017147146A1 (en)	2016-02-23	2017-08-31	Concentric Analgesics, Inc.	Prodrugs of phenolic trpv1 agonists
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
BR112018070199A2 (pt)	2016-04-01	2019-01-29	Therapeuticsmd Inc	composição farmacêutica de hormônio esteroide
WO2017176652A2 (en)	2016-04-04	2017-10-12	Sinopia Biosciences, Inc.	Treating extrapyramidal syndrome using trapidil
EP3439591B1 (de)	2016-04-05	2020-09-23	ForSight Vision4, Inc.	Implantierbare okulare arzneimittelabgabevorrichtungen
US10143687B2 (en)	2016-04-11	2018-12-04	Neurocea, LLC	Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
US10292977B2 (en)	2016-04-11	2019-05-21	Neurocea, LLC	Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
EP3463576A4 (de)	2016-05-25	2020-01-15	Concentric Analgesics, Inc.	Prodrugs von phenolischen trpv1-agonisten in kombination mit lokalanästhetika und vasokonstriktoren für verbesserte lokalanästhesie
WO2017205762A1 (en)	2016-05-27	2017-11-30	Pharmacyclics Llc	Inhibitors of interleukin-1 receptor-associated kinase
WO2017205769A1 (en)	2016-05-27	2017-11-30	Pharmacyclics Llc	Inhibitors of interleukin-1 receptor-associated kinase
WO2017205766A1 (en)	2016-05-27	2017-11-30	Pharmacyclics Llc	Inhibitors of interleukin-1 receptor-associated kinase
AU2017298142B2 (en)	2016-07-18	2021-11-11	Arthrosi Therapeutics, Inc.	Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemia
WO2018039621A1 (en)	2016-08-26	2018-03-01	Curtana Pharmaceuticals, Inc.	Inhibition of olig2 activity
US10736905B1 (en)	2016-09-09	2020-08-11	Shahin Fatholahi	Nefopam dosage forms and methods of treatment
KR20190085046A (ko)	2016-11-16	2019-07-17	어바이드 테라퓨틱스, 인크.	약학 제제
PL3964503T3 (pl)	2016-11-16	2024-04-02	H. Lundbeck A/S	Krystaliczna postać inhibitora magl
EP3565834A1 (de)	2017-01-04	2019-11-13	The Research Institute at Nationwide Children's Hospital	Antikörperfragmente zur behandlung von biofilmbedingten erkrankungen
US11564982B2 (en)	2017-01-04	2023-01-31	Research Institute At Nationwide Children's Hospital	DNABII vaccines and antibodies with enhanced activity
JP2020503950A (ja)	2017-01-06	2020-02-06	クロノセラピューティクスインコーポレイテッドＣｈｒｏｎｏＴｈｅｒａｐｅｕｔｉｃｓＩｎｃ．	経皮薬剤送達の装置及び方法
CN115444410A (zh)	2017-01-23	2022-12-09	雅培糖尿病护理公司	用于***体内分析物传感器的施加器及组件
US10702495B2 (en)	2017-02-20	2020-07-07	Nexien Biopharma, Inc.	Method and compositions for treating dystrophies and myotonia
WO2018175489A1 (en)	2017-03-21	2018-09-27	Abbott Diabetes Care Inc.	Methods, devices and system for providing diabetic condition diagnosis and therapy
WO2018200885A1 (en)	2017-04-26	2018-11-01	Neurocentria, Inc.	Magnesium compositions and methods of use
KR20200086257A (ko)	2017-09-01	2020-07-16	유니버시티 오브 워싱톤	감각 모 세포 사멸 예방 또는 치료용 화합물의 결정질 형태
US11446311B2 (en)	2017-09-08	2022-09-20	Shahin Fatholahi	Methods for treating pain associated with sickle cell disease
US10736874B1 (en)	2017-09-08	2020-08-11	Shahin Fatholahi	Methods for treating pain associated with sickle cell disease
US11331022B2 (en)	2017-10-24	2022-05-17	Dexcom, Inc.	Pre-connected analyte sensors
US20190120785A1 (en)	2017-10-24	2019-04-25	Dexcom, Inc.	Pre-connected analyte sensors
BR112020010053A2 (pt)	2017-11-21	2020-11-03	Forsight Vision4, Inc.	aparelho para troca de fluido para sistema de liberação de porta expansível e métodos de uso do mesmo
WO2019161307A1 (en)	2018-02-16	2019-08-22	Esperion Therapeutics, Inc.	Sustained release formulations of bempedoic acid
US11759417B2 (en)	2018-02-28	2023-09-19	Shanghai Wd Pharmaceutical Co., Ltd	Pharmaceutical composition and preparation method therefor and use thereof
WO2019169112A1 (en)	2018-02-28	2019-09-06	Curtana Pharmaceuticals, Inc.	Inhibition of olig2 activity
US11000471B2 (en)	2018-03-05	2021-05-11	Kashiv Specialty Pharmaceuticals, Llc	Programmable pharmaceutical compositions for chrono drug release
CN112118886B (zh)	2018-05-23	2022-08-23	上海汉都医药科技有限公司	活性药物成分的控释***及其制备方法
US11911513B2 (en)	2018-05-23	2024-02-27	Shanghai Wd Pharmaceutical Co., Ltd	Controlled-release system of active pharmaceutical ingredient and preparation method therefor
JP7420797B2 (ja)	2018-05-29	2024-01-23	モーニングサイドベンチャーインベストメンツリミテッド	薬剤送達の方法及びシステム
US10905667B2 (en)	2018-07-24	2021-02-02	Bayer Pharma Aktiengesellschaft	Orally administrable modified-release pharmaceutical dosage form
JOP20210019A1 (ar)	2018-07-24	2021-01-24	Bayer Ag	شكل جرعة صيدلانية تعطى عن طريق الفم ذات اطلاق مُعدّل
CN112469398A (zh)	2018-07-24	2021-03-09	拜耳公司	可口服给药并具有缓释作用的药物剂型
AU2019310118A1 (en)	2018-07-27	2021-03-11	Concentric Analgesics, Inc.	Pegylated prodrugs of phenolic TRPV1 agonists
CN114040760A (zh)	2018-12-31	2022-02-11	拜欧米富士恩公司	Menin-mll相互作用的不可逆抑制剂
WO2020190890A1 (en)	2019-03-15	2020-09-24	Unicycive Therapeutics Inc.	Nicorandil derivatives
USD1002852S1 (en)	2019-06-06	2023-10-24	Abbott Diabetes Care Inc.	Analyte sensor device
EP3750528A1 (de)	2019-06-11	2020-12-16	Nexien Biopharma, Inc.	Zusammensetzungen zur behandlung von dystrophien und myotonie
US20220275064A1 (en)	2019-07-08	2022-09-01	Research Institute At Nationwide Children's Hospital	Antibody compositions for disrupting biofilms
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations
AU2021259496A1 (en)	2020-04-21	2022-11-10	H. Lundbeck A/S	Synthesis of a monoacylglycerol lipase inhibitor
PL4153136T3 (pl)	2020-06-10	2024-06-24	Auspex Pharmaceuticals, Inc.	Osmotyczne postacie dawkowania zawierające deutetrabenazynę i sposoby ich stosowania
EP4263542A1 (de)	2020-12-16	2023-10-25	Biomea Fusion, Inc.	Kondensierte pyrimidinverbindungen als inhibitoren der menin-mll-interaktion
USD999913S1 (en)	2020-12-21	2023-09-26	Abbott Diabetes Care Inc	Analyte sensor inserter
CA3204457A1 (en)	2021-01-06	2022-07-14	Ben SESSA	Mdma in the treatment of alcohol use disorder
WO2022238507A1 (en)	2021-05-11	2022-11-17	Awakn Ls Europe Holdings Limited	Therapeutic aminoindane compounds and compositions
WO2022247952A1 (zh) *	2021-05-28	2022-12-01	上海博志研新药物技术有限公司	硝苯地平美托洛尔缓释组合物、其制备方法及应用
WO2022256720A2 (en)	2021-06-03	2022-12-08	Arcadia Medicine, Inc.	Enantiomeric entactogen compositions and methods of their use
EP4384179A1 (de)	2021-08-11	2024-06-19	Biomea Fusion, Inc.	Kovalente inhibitoren der menin-mll-interaktion gegen diabetes mellitus
CA3229150A1 (en)	2021-08-20	2023-02-23	Biomea Fusion, Inc.	Crystalline form of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo -2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, an irreversible menin-mll inhibitor for the treatment of cance
US12043605B2 (en)	2021-08-23	2024-07-23	Alexander Shulgin Research Institute, Inc.	Deuterated empathogens
WO2023027966A1 (en)	2021-08-24	2023-03-02	Biomea Fusion, Inc.	Pyrazine compounds as irreversible inhibitors of flt3
WO2023039240A1 (en)	2021-09-13	2023-03-16	Biomea Fusion, Inc.	IRREVERSIBLE INHIBITORS OF KRas
WO2023086341A1 (en)	2021-11-09	2023-05-19	Biomea Fusion, Inc.	Inhibitors of kras
KR20230071712A (ko)	2021-11-16	2023-05-23	오즈온바이오 주식회사	산 민감성 무기성분을 포함하는 삼투성 제제 조성물
WO2023129667A1 (en)	2021-12-30	2023-07-06	Biomea Fusion, Inc.	Pyrazine compounds as inhibitors of flt3
WO2023139163A1 (en)	2022-01-19	2023-07-27	Awakn Ls Europe Holdings Limited	1,3-benzodioxole esters and their therapeutic use
CN115490316B (zh) *	2022-01-24	2023-09-12	成都理工大学	一种可再利用的地下水营养物质缓释胶囊体
USD1033637S1 (en)	2022-01-24	2024-07-02	Forsight Vision4, Inc.	Fluid exchange device
WO2023156565A1 (en)	2022-02-16	2023-08-24	Awakn Ls Europe Holdings Limited	Bridged ring compounds and their therapeutic use as cns agents
WO2023235618A1 (en)	2022-06-03	2023-12-07	Biomea Fusion, Inc.	Fused pyrimidine compounds as inhibitors of menin
WO2023240186A1 (en)	2022-06-08	2023-12-14	Auspex Pharmaceuticals, Inc.	Osmotic dosage forms comprising deutetrabenazine and methods of use thereof
US20240010649A1 (en)	2022-07-06	2024-01-11	Oppilan Pharma Limited	Crystalline forms of an s1p receptor modulator
US11931224B1 (en) *	2022-12-19	2024-03-19	Robert Parker	Tooth pod

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3247066A (en) *	1962-09-12	1966-04-19	Parke Davis & Co	Controlled release dosage form containing water-swellable beadlet
US3867329A (en) *	1972-08-25	1975-02-18	Polysciences Inc	Composition for a hydrogel dilator article of manufacture and method for making same
US4111201A (en) *	1976-11-22	1978-09-05	Alza Corporation	Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4111203A (en) *	1976-11-22	1978-09-05	Alza Corporation	Osmotic system with means for improving delivery kinetics of system
US4111202A (en) *	1976-11-22	1978-09-05	Alza Corporation	Osmotic system for the controlled and delivery of agent over time
US4203439A (en) *	1976-11-22	1980-05-20	Alza Corporation	Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4203440A (en) *	1978-10-23	1980-05-20	Alza Corporation	Device having variable volume chamber for dispensing useful agent
US4210139A (en) *	1979-01-17	1980-07-01	Alza Corporation	Osmotic device with compartment for governing concentration of agent dispensed from device
US4235236A (en) *	1979-02-12	1980-11-25	Alza Corporation	Device for dispensing drug by combined diffusional and osmotic operations

1980
- 1980-11-25 US US06/210,176 patent/US4327725A/en not_active Expired - Lifetime
1981
- 1981-07-22 EP EP81303354A patent/EP0052917B1/de not_active Expired
- 1981-07-22 DE DE8181303354T patent/DE3172338D1/de not_active Expired
- 1981-07-22 AT AT81303354T patent/ATE15606T1/de not_active IP Right Cessation
- 1981-09-21 JP JP56149298A patent/JPS6043045B2/ja not_active Expired
1992
- 1992-06-26 MX MX9203553A patent/MX174160B/es unknown

Also Published As

Publication number	Publication date
EP0052917A2 (de)	1982-06-02
US4327725A (en)	1982-05-04
DE3172338D1 (en)	1985-10-24
JPS5793065A (en)	1982-06-09
JPS6043045B2 (ja)	1985-09-26
MX9203553A (es)	1992-09-01
EP0052917A3 (en)	1982-10-06
MX174160B (es)	1994-04-25
EP0052917B1 (de)	1985-09-18

Legal Events

Date	Code	Title	Description
1986-01-15	UEP	Publication of translation of european patent specification
2001-10-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE15606T1 (de)	1985-10-15	Durch osmose wirksame vorrichtung mit hydrogel als osmotisches mittel.
ES498887A0 (es)	1982-05-01	Perfeccionamientos introducidos en una bomba de fluido de accion simple, accionable acuaticamemte.
BR8106194A (pt)	1982-06-15	Bomba alternativa acionada por fluido
IT1144374B (it)	1986-10-29	Procedimento e dispositivo per identificare le discontinuita in un flusso di fluido
ES517079A0 (es)	1984-10-01	Procedimiento de inmuno-analisis para determinar una iodotironina en un fluido biologico.
NL182751C (nl)	1988-05-02	Ultrageluidsomzetter en de toepassing daarvan in een doorstroommeter.
BR8102560A (pt)	1982-08-17	Filtro de fluido da transmissao e sistema de circulacao de fluido numa transmissao automotivo
IT8124230A0 (it)	1981-09-30	Dispositivo modificatore del flusso di un fluido.
BR8107931A (pt)	1982-09-14	Dispositivo para captar e explorar uma pressao,especialmente pressao de fluido
BR8100262A (pt)	1981-08-04	Valvula para adicionar ingredientes ou efetuar a amostragem do fluido de passagem atraves da valvula
ES286420U (es)	1985-11-01	Dispositivo osmotico.
ES513163A0 (es)	1983-06-01	Perfeccionamientos en dispositivos de compresion de fluidos.
IT7920294A0 (it)	1979-02-16	Dispositivo per la determinazione elettrochimica transcutanea della pressione parziale di ossigeno nel sangue.
BR8406912A (pt)	1985-05-21	Sistema de pressao de fluido e dispositivo de valvula
IT8121922A0 (it)	1981-05-22	Valvola e dispositivo per misurare la pressione sanguigna dotato di valvola.
IT8168070A0 (it)	1981-07-30	Procedimento per eliminare la torbidita di un fluido biologico e reagente utilizzabile nel procedimento
ES501813A0 (es)	1982-11-01	Mejoras introducidas en dispositivos de acoplamiento por fluido viscoso, con cizalladura.
SE8503705L (sv)	1987-02-06	Ventilanordning
BR8100364A (pt)	1981-08-11	Composicao contendo polimero hidrossoluvel, vazavel, liquida, para espessar meios aquosos, e fluido de tratamento ou perfuracao de pocos
BR7702067A (pt)	1978-01-17	Dispositivo de valvula tripla operado por pressao de fluido;e dispositivo de valvula operado por pressao de fluido
JPS57179737A (en)	1982-11-05	Flow cell
ES514979A0 (es)	1983-10-16	Perfeccionamientos en bombas de fluido rotativas.
SU599581A1 (ru)	1978-10-30	Электрогидравлическое устройство дл создани импульсных давлений в жидкости
SU464360A1 (ru)	1975-03-25	Устройство дл гидродинамической обработки
IT7925103A0 (it)	1979-08-14	Generatore di fluido in pressione con valvola proporzionatrice in un sol pezzo.